Improvements in or relating to organic compounds
Patent Information
- Application Number
- JP2023530934
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2020-11-24
- Filing Date
- 2021-11-23
- Publication Date
- 2024-11-29
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Existing perfume encapsulation technologies, while environmentally friendly, lack improvements in overall sustainability and efficiency.
Development of encapsulated perfume compositions comprising at least 75 wt.% biodegradable components, encapsulated in a water-soluble matrix using biodegradable materials like starch, maltodextrin, and polysaccharides, with core-shell microcapsules for controlled fragrance release.
Enhances the ecological footprint of perfume encapsulation by ensuring high biodegradability and controlled fragrance release, meeting consumer demands for sustainability and effective odor delivery.
Abstract
Description
[Technical Field]
[0001] The present invention relates to encapsulated compositions comprising a fragrance composition enclosed in a water-soluble matrix, a process for producing such compositions, and uses for obtaining consumer products of such compositions. [Background technology]
[0002] The incorporation of functional materials into consumer products such as home care, personal care, and fabric care products is well known. Functional materials include, for example, fragrances, cosmetic surfactants, and biologically active ingredients such as biocides and drugs.
[0003] Spray drying is a well-known technique for encapsulating fragrances. Such spray-dried fragrance compositions are typically prepared from an emulsion of the fragrance to be encapsulated, which is then sprayed into a drying chamber. In this process, a biopolymer with surfactant properties is commonly used as an emulsifier, which, upon spray drying, forms a water-soluble matrix in which the fragrance is trapped. For example, WO 1999 / 055819 A1 relates to a high-impact flavor accord encapsulated with modified starch.
[0004] Such spray-dried compositions provide a powder fragrance form that is simple to manufacture and exhibits the benefits of a good scent. Furthermore, given the increasing consumer awareness of environmental and resource conservation these days, their encapsulations are becoming even more attractive, as they are often based on bio-resource materials. Spray-dried compositions thus have a low ecological footprint and enable highly efficient encapsulation of fragrances. They also exhibit beneficial release properties. [Overview of the project]
[0005] However, despite these advantages, there remains a need to provide the aforementioned types of fragrance compositions that exhibit improved overall sustainability. This problem is resolved by the matters of the independent claims.
[0006] The present invention relates to an encapsulated composition comprising a fragrance composition enclosed in a water-soluble matrix. The fragrance composition comprises, preferably, one or more biodegradable components, at least one, preferably at least two, more preferably at least four, even more preferably at least eight, and even more preferably at least sixteen. The biodegradable components are present at a total concentration of at least 75 wt.-%, preferably at least 80 wt.-%, more preferably at least 85 wt.-%, even more preferably at least 90 wt.-%, and even more preferably at least 95 wt.-%, based on the total weight of the fragrance composition. [Modes for carrying out the invention]
[0007] In the context of this invention, “biodegradable component” is a component that meets the “inherently biodegradable” and / or “readily biodegradable” pass criteria in at least one OECD biodegradability test. To avoid ambiguity, this means that if a component passes one test but fails one or more other tests, the pass result takes precedence over the results of the other tests. "Ultimate biodegradability" refers to the complete breakdown of a chemical into water, carbon dioxide, and new biomass.
[0008] For assessing the "easily biodegradable" criteria, biodegradation studies can be selected from the group consisting of OECD Method 301C, OECD Method 301D, OECD Method 301F, and OECD Method 310. These methods are suitable for volatile materials.
[0009] OECD Method 301C, OECD Method 301D, and OECD Method 301F are described in the OECD Guidelines for the Testing of Chemicals, Section 3, Test No. 301: Ready Biodegradability (adopted July 17, 1992; https: / / doi.org / 10.1787 / 9789264070349-en).
[0010] OECD Method 310 is described in the OECD Guidelines for the Testing of Chemicals, Section 3, Test No. 310: Ready Biodegradability - CO2 in sealed vessels (Headspace Test) (adopted: March 23, 2006; amended: September 26, 2014; https: / / doi.org / 10.1787 / 9789264016316-en).
[0011] In a specific aspect of the present invention, the pass criterion for "easily biodegradable" is evaluated according to OECD Method 301F, which refers to manometric respirometry. In this method, the pass level for "easily biodegradable" is reaching 60% of the theoretical oxygen demand and / or chemical oxygen demand. This pass value must be achieved within 10 days of a 28-day test period. The 10-day period begins when the degree of biodegradation reaches 10% of the theoretical oxygen demand and / or chemical oxygen demand and must be completed by the 28th day of the test. A preferred method for carrying out OECD Method 301F is provided below herein.
[0012] If a positive result is obtained in a test for easy biodegradability, it is assumed that the chemical substance will undergo rapid and ultimate biodegradation in the environment in question (Introduction to the OECD Guidelines for the Testing of Chemicals, Section 3, Part 1: Principles and Strategies Related to the Testing of Degradation of Organic Chemicals; Adopted: July 2003).
[0013] For assessing the acceptance criteria for "intrinsic biodegradability," biodegradation studies can be conducted using OECD Method 302C, although OECD Method 301F, while having different acceptance criteria, can also be used. These methods are also suitable for volatile materials.
[0014] OECD Method 302C is described in the OECD Guidelines for the Testing of Chemicals, Section 3, Test No. 302C: Inherent Biodegradability: Modified MITI Test (II) (adopted May 12, 1981; amended September 8, 2009; https: / / doi.org / 10.1787 / 9789264070400-en).
[0015] In specific aspects of the present invention, the acceptance criteria for "inherently biodegradable" are evaluated according to OECD Method 302C. In this method, the acceptance level for "inherently biodegradable" is, subsequently, reaching 70% of the theoretical oxygen demand. There is no time limit for reaching this level.
[0016] A biodegradation rate above 70% is essential and can be considered as evidence of ultimate biodegradability (OECD Guidelines for the Testing of Chemicals, Section 3, Part 1: Principles and Strategies Related to the Testing of Degradation of Organic Chemicals; adopted: July 2003).
[0017] When OECD Method 301F is used to assess the pass criteria for "inherent biodegradability", the pass level is 60% of the theoretical oxygen demand and / or chemical oxygen demand. This pass value can be reached after a 28-day test period (usually extended up to 60 days), and the 10-day window does not apply.
[0018] In this context, when the component is an essential oil, if all of its constituent substances present at a level ≧ 1 wt.-% meet the definitions of "inherent biodegradability" and / or "readily biodegradable" as defined herein, it is considered a "biodegradable component". However, essential oils can also be the subject of the above biodegradation tests.
[0019] The present type of encapsulated composition typically has a proportion of perfume composition up to a maximum of 50 wt.-% relative to the total weight of the composition, meaning that a significant part of the mass of the encapsulated composition consists of the perfume composition. As a result, the overall ecological footprint of the capsules can be significantly improved - regardless of the matrix material - by using biodegradable component(s) in the perfume composition. Biodegradation is an important process for the removal of perfume components in the environment.
[0020] In specific embodiments of the present invention, the biodegradable component(s) are selected from the group consisting of: ACETOPHENONE EXTRA (1-phenylethanone); ADOXAL (2,6,10-trimethylundeca-9-enal); AGRUMEX (2-(tert-butyl)cyclohexyl acetate); ALCOHOL C 6 HEXYLIC (hexane-1-ol); ALDEHYDE C 10 DECYLIC (decanal); ALDEHYDE C 11 MOA (2-methyldecanal); ALDEHYDE C 11 UNDECYLENIC (undeca-10-enal); ALDEHYDE C 110 UNDECYLIC (undecal); ALDEHYDE C 12 LAURIC (dodecanal); ALDEHYDE C 12 MNA PURE (2-methylundecal); ALDEHYDE C 6 HEXYLIC FOOD GRADE (hexane-1-al); ALDEHYDE C 8 OCTYLIC FOOD GRADE (Octanal); ALDEHYDE C 9 ISONONYLIC (3,5,5-Trimethylhexanal); ALDEHYDE C 9 NONYLIC FOOD GRADE (Nonanal); ALDEHYDE ISO C 11 ((E)-Undeca-9-Enal); ALLYL AMYL GLYCOLATE (Propa-2-Enyl 2-(3-Methylbutoxy)acetate); ALLYL CAPROATE (Propa-2-Enylhexanoate); ALLYL CYCLOHEXYL PROPIONATE (Propa-2-Enyl 3-Cyclohexylpropanoate); ALLYL OENANTHATE (propa-2-enylheptanoate); AMBERKETAL (3,8,8,11a-tetramethyldodecahydro-1H-3,5a-epoxynaphtho[2,1-c]oxepine); AMBRETTOLIDE ((Z)-oxacycloheptadeca-10-en-2-one); AMBROFIX ((3aR,5aS,9aS,9bR)-3a,6,6,9a-tetramethyl-2,4,5,5a,7,8,9,9b-octahydro-1H-benzo[e][1]benzofuran); AMYL BUTYRATE (pentylbutanoate);AMYL CINNAMIC ALDEHYDE ((Z)-2-benzylidene heptanal); AMYL SALICYLATE (pentyl 2-hydroxybenzoate); ANETHOLE ((E)-1-methoxy-4-(propa-1-en-1-yl)benzene); ANISYL ACETATE (4-methoxybenzyl acetate); APHERMATE (1-(3,3-dimethylcyclohexyl)ethylformate); AUBEPINE PARA CRESOL (4-methoxybenzaldehyde); AURANTIOL ((E)-methyl 2-((7-hydroxy-3,7-dimethyloctylidene)amino)benzoate); BENZALDEHYDE (benzaldehyde); BENZYL ACETATE (benzyl acetate); BENZYL ACETONE (4-phenylbutan-2-one); BENZYL ALCOHOL (phenylmethanol); BENZYL BENZOATE (benzyl benzoate); BENZYL CINNAMATE (benzyl 3-phenylpropane-2-enoate); BENZYL SALICYLATE (benzyl 2-hydroxybenzoate); BICYCLO NONALACTONE (octahydro-2H-chromen-2-one); BORNEOL CRYSTALS ((1S,2S,4S)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-ol); BORNYL ACETATE ((2S,4S)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl acetate); BOURGEONAL (3-(4-(tert-butyl)phenyl)propanal); BUTYL ACETATE (butyl acetate); BUTYL CYCLOHEXYL ACETATE PARA(4-(tert-butyl)cyclohexyl acetate); CAMPHOR((1S,4S)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-one); CARVONE LAEVO((5R)-2-methyl-5-propa-1-en-2-ylcyclohexa-2-en-1-one); CEDRYL METHYL ETHER((1R,6S,8aS)-6-methoxy-1,4,4,6-tetramethyloctahydro-1H-5,8a-methanoazulene);CETONE V((E)-1-(2,6,6-trimethylcyclohexa-2-en-1-yl)hepta-1,6-dien-3-one); CINNAMIC ALCOHOL SYNTHETIC((E)-3-phenylpropa-2-en-1-ol); CINNAMIC ALDEHYDE((2E)-3-phenylpropa-2-enal); CINNAMYL ACETATE((E)-3-phenylpropa-2-en-1-yl acetate); CIS-3-HEXENOL((Z)-hexa-3-en-1-ol); CIS JASMONE ((Z)-3-methyl-2-(penta-2-en-1-yl)cyclopenta-2-enone); CITRAL ((E)-3,7-dimethylocta-2,6-dienal); CITRONELLAL (3,7-dimethylocta-6-enal); CITRONELLOL (3,7-dimethylocta-6-en-1-ol); CITRONELLYL ACETATE (3,7-dimethylocta-6-en-1-yl acetate); CITRONELLYL FORMATE (3,7-dimethylocta-6-en-1-yl formate); CITRONELLYL NITRILE (3,7-dimethylocta-6-ennitrile); CLONAL (dodecanenitrile); CORANOL (4-cyclohexyl-2-methylbutan-2-ol); CORYLONE DRIED (2-hydroxy-3-methylcyclopenta-2-enone); COSMONE ((Z)-3-methylcyclotetradeca-5-enone); COUMARIN PURE CRYSTALS (2H-chromen-2-one); CRESYL METHYL ETHER PARA (1-methoxy-4-methylbenzene); CUMIN NITRILE (4-isopropylbenzonitrile); CYCLAMEN ALDEHYDE EXTRA (3-(4-isopropylphenyl)-2-methylpropanal); DAMASCENONE ((E)-1-(2,6,6-trimethylcyclohexa-1,3-dien-1-yl)buta-2-en-1-one); DAMASCONE ALPHA ((E)-1-(2,6,6-trimethylcyclohexa-2-en-1-yl)buta-2-en-1-one); DECALACTONE GAMMA (5-hexyloxolan-2-one);DECENAL-4-TRANS((E)-deca-4-enal); DIHYDRO ANETHOLE(1-methoxy-4-propylbenzene); DIHYDRO MYRCENOL(2,6-dimethylocta-7-en-2-ol); DIMETHYL BENZYL CARBINYL ACETATE(2-methyl-1-phenylpropane-2-yl acetate); DIMETHYL BENZYL CARBINYL BUTYRATE(2-methyl-1-phenylpropane-2-yl butanoate); DIMETOL(2,6-dimethylheptan-2-ol); DIPHENYL OXIDE (oxydibenzene); DODECENAL ((E)-dodeca-2-enal); EBANOL ((E)-3-methyl-5-(2,2,3-trimethylcyclopenta-3-en-1-yl)penta-4-en-2-ol); ESTERLY (ethylcyclohexyl carboxylate); ETHYL ACETATE (ethyl acetate); ETHYL ACETOACETATE (ethyl 3-oxobutanoate); ETHYL CINNAMATE (ethyl 3-phenylpropane-2-enoate); ETHYL HEXANOATE (ethyl hexanoate); ETHYL LINALOOL ((E)-3,7-dimethylnonano-1,6-dien-3-ol); ETHYL MALTOL (2-ethyl-3-hydroxy-4H-pyran-4-one); ETHYL METHYL-2-BUTYRATE (ethyl 2-methylbutanoate); ETHYL OENANTHATE (ethylheptanoate); ETHYL VANILLIN (3-ethoxy-4-hydroxybenzaldehyde); ETHYLENE BRASSYLATE (1,4-dioxacycloheptadecane-5,17-dione); EUCALYPTOL NATURAL ((1s,4s)-1,3,3-trimethyl-2-oxabicyclo[2.2.2]octane); EUGENOL (4-allyl-2-methoxyphenol); EVERNYL (methyl 2,4-dihydroxy-3,6-dimethylbenzoate); FENCHYL ALCOHOL ((1S,2R,4R)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-ol); FENNALDEHYDE (3-(4-methoxyphenyl)-2-methylpropanal);FLORHYDRAL (3-(3-isopropylphenyl)butanal); FLOROSA HC (tetrahydro-4-methyl-2-(2-methylpropyl)-2H-pyran-4-ol); FRESKOMENTHE (2-(sec-butyl)cyclohexanone); FRUTONILE (2-methyldecanonitrile); GALBANONE PURE (1-(5,5-dimethylcyclohexa-1-en-1-yl)penta-4-en-1-one); GERANIOL ((E)-3,7-dimethylocta-2,6-dien-1-ol); GERANYL ACETATE ((E)-3,7-dimethylocta-2,6-dien-1-yl acetate); GERANYL ACETONE ((E)-6,10-dimethylundeca-5,9-dien-2-one); HABANOLIDE ((E)-oxacyclohexadeca-12-en-2-one); HEDIONE (methyl 3-oxo-2-pentylcyclopentane acetate); HELIOTROPINE CRYSTALS (benzo[d][1,3]dioxol-5-carbaldehyde); HEXENAL-2-TRANS ((E)-hexa-2-enal); HEXENOL-3-CIS ((Z)-hexa-3-en-1-ol); HEXENYL-3-CIS ACETATE ((Z)-hexa-3-en-1-yl acetate); HEXENYL-3-CIS ISOBUTYRATE ((Z)-hexa-3-en-1-yl 2-methylpropanoate); HEXENYL-3-CIS SALICYLATE ((Z)-Hexa-3-en-1-yl 2-hydroxybenzoate); HEXYL ACETATE (Hexyl acetate); HEXYL CINNAMIC ALDEHYDE ((E)-2-benzylidene octanal); HEXYL ISOBUTYRATE (Hexyl 2-methylpropanoate); HEXYL SALICYLATE (Hexyl 2-hydroxybenzoate); HYDROXYCITRONELLAL (7-hydroxy-3,7-dimethyloctanal); INDOLE PURE (1H-indole); IONONE BETA ((E)-4-(2,6,6-trimethylcyclohexa-1-en-1-yl)buta-3-en-2-one);IRISONE ALPHA((E)-4-(2,6,6-trimethylcyclohexa-2-en-1-yl)buta-3-en-2-one); ISOAMYL ACETATE EXTRA(3-methylbutyl acetate); ISOEUGENOL((E)-2-methoxy-4-(propa-1-en-1-yl)phenol); ISOMENTHONE DL(2-isopropyl-5-methylcyclohexanone); ISOPROPYL METHYL-2-BUTYRATE(isopropyl 2-methylbutanoate); ISORALDEINE((E)-3-methyl-4-(2,6,6-trimethylcyclohexa-2-en-1-yl)buta-3-en-2-one); JASMONE CIS((Z)-3-methyl-2-(penta-2-en-1-yl)cyclopenta-2-enone); JASMONYL(3-butyl-5-methyltetrahydro-2H-pyran-4-yl acetate); JASMOPYRANE FORTE(3-pentyltetrahydro-2H-pyran-4-yl acetate); LIFFAROME((Z)-hexa-3-en-1-yl methylcarbonate); LILIAL(3-(4-(tert-butyl)phenyl)-2-methylpropanal); LIMONENE, LIMONENE, or LAEVO, LIMONENE DEXTRO(1-methyl-4-propa-1-en-2-ylcyclohexene); LINALOOL OXIDE (2-(5-methyl-5-vinyltetrahydrofuran-2-yl)propane-2-ol); LINALOOL (3,7-dimethylocta-1,6-dien-3-ol); LINALYL ACETATE (3,7-dimethylocta-1,6-dien-3-yl acetate); MAHONIAL ((4E)-9-hydroxy-5,9-dimethyl-4-decanal); MALTOL (3-hydroxy-2-methyl-4H-pyran-4-one); MANZANATE (ethyl 2-methylpentanoate); MAYOL ((4-isopropylcyclohexyl)methanol); MEFROSOL (3-methyl-5-phenylpentan-1-ol); MELONAL (2,6-dimethylhepta-5-enal); MENTHOL, MENTHOL LAEVO, or MENTHOL RACEMIC (2-isopropyl-5-methylcyclohexanol);MENTHONE, ISOMENTHONE, MENTHONE LAEVO, or MENTHONE RACEMIC (2-isopropyl-5-methylcyclohexanone); METHYL ANTHRANILATE EXTRA (methyl 2-aminobenzoate); METHYL BENZOATE (methyl benzoate); METHYL CINNAMATE (methyl 3-phenylpropane-2-enoate); METHYL DIANTILIS (2-ethoxy-4-(methoxymethyl)phenol); METHYL DIHYDRO ISOJASMONATE (methyl 2-hexyl-3-oxocyclopentan-1-carboxylate); METHYL HEPTENONE (6-methylhepta-5-en-2-one); METHYL LAITONE (8-methyl-1-oxaspiro[4.5]decane-2-one); METHYL OCTYNE CARBONATE (methylnona-2-i; Noate); METHYL SALICYLATE (methyl 2-hydroxybenzoate); MUSCENONE ((Z)-3-methylcyclopentadeca-5-enone); MYRALDENE (4-(4-methylpenta-3-en-1-yl)cyclohexa-3-encarbaldehyde); MYRCENE (7-methyl-3-methyleneocta-1,6-diene); MYSTIKAL (2-methylundecanoic acid); NECTARYL (2-(2-(4-methylcyclohexa-3-en-1-yl)propyl)cyclopentanone); NEOFOLIONE ((E)-methylnona-2-enoate); NEROLEX ((2Z)-3,7-dimethylocta-2,6-dien-1-ol); NEROLIDOL ((E)-3,7,11-trimethyldodeca-1,6,10-trien-3-ol); NEROLINE CRYSTALS (2-ethoxynaphthalene); NERYL ACETATE HC ((Z)-3,7-dimethylocta-2,6-diene-1-yl acetate); NIRVANOLIDE ((E)-13-methyloxacyclopentadeca-10-en-2-one); NONADIENAL ((2E,6Z)-nona-2,6-dienal); NONADIENOL-2,6 ((2Z,6E)-2,6-nonadiene-1-ol); NONALACTONE GAMMA (5-pentyloxolan-2-one); NONENAL-6-CIS ((Z)-nona-6-enal); NONENOL-6-CIS ((Z)-nona-6-en-1-ol); NOPYL ACETATE (2-(6,6-dimethylbicyclo[3.1.1]hepta-2-en-2-yl)ethyl acetate); NYMPHEAL (3-(4-(2-methylpropyl)-2-methylphenyl)propanal); OCTANONE-2 (octan-2-one); ORANGER CRYSTALS (1-(2-naphthalenyl)-ethanone); PANDANOL ((2-methoxyethyl)benzene); PEACH PURE (5-heptyldihydrofuran-2(3H)-one); PELARGOL (3,7-dimethyloctan-1-ol); PHARAONE (2-cyclohexylhepta-1,6-dien-3-one); PHENOXY ETHYL ISOBUTYRATE (2-(phenoxy)ethyl 2-methylpropanoate);PHENYL ACETALDEHYDE (2-phenyl-ethanol); PHENYL ETHYL ACETATE (2-phenylethyl acetate); PHENYL ETHYL ALCOHOL (2-phenylethanol); PHENYL ETHYL ISOBUTYRATE (2-phenylethyl 2-methylpropanoate); PHENYL ETHYL PHENYL ACETATE (2-phenylethyl 2-phenyl acetate); PHENYL PROPYL ALCOHOL (3-phenylpropane-1-ol); PINENE BETA (6,6-dimethyl-2-methylenebicyclo[3.1.1]heptane); PINOACETALDEHYDE (3-(6,6-dimethylbicyclo[3.1.1]hepta-2-en-2-yl)propanal); POMAROSE ((2E,5E)-5,6,7-trimethylocta-2,5-dien-4-one); PRECYCLEMONE B (1-methyl-4-(4-methylpenta-3-en-1-yl)cyclohexa-3-encarbaldehyde); PRENYL ACETATE (3-methylbuta-2-en-1-yl acetate); RASPBERRY KETONE (4-(4-hydroxyphenyl)butan-2-one); ROSE OXIDE (4-methyl-2-(2-methylpropa-1-en-1-yl)tetrahydro-2H-pyran); ROSYRANE SUPER(4-methyl-2-phenyl-3,6-dihydro-2H-pyran); SANDALORE EXTRA(3-methyl-5-(2,2,3-trimethylcyclopenta-3-en-1-yl)pentan-2-ol); SCENTAURUS CLEAN(ethyl(Z)-2-acetyl-4-methyltrideca-2-enoate); SCENTAURUS JUICY(4-(dodecylthio)-4-methylpentan-2-one); SILVANONE SUPRA(cyclopentadecanone, hexadecanolide); STYRALLYL ACETATE(1-phenylethyl acetate); SUPER MUGUET((E)-6-ethyl-3-methylocta-6-en-1-ol); SYLKOLIDE((E)-2-((3,5-dimethylhexa-3-en-2-yl)oxy)-2-methylpropylcyclopropanecarboxylate);TERPINENE GAMMA (1-methyl-4-propane-2-ylcyclohexa-1,4-diene); TERPINEOL ALPHA (2-(4-methyl-1-cyclohexa-3-enyl)propane-2-ol); TERPINEOL PURE (2-(4-methylcyclohexa-3-en-1-yl)propane-2-ol); TERPINOLENE (1-methyl-4-(propane-2-ylidene)cyclohexa-1-ene); TERPINYL ACETATE (2-(4-methyl-1-cyclohexa-3-enyl)propane-2-yl acetate); TETRAHYDRO LINALOOL (3,7-dimethyloctan-3-ol); THIBETOLIDE (oxacyclohexadecan-2-one); THYMOL (2-isopropyl-5-methylphenol); TOSCANOL (1-(cyclopropylmethyl)-4-methoxybenzene); TRIDECENE-2-NITRILE ((E)-trideca-2-ennitrile); TRIFERNAL (3-phenylbutanal); TROPIONAL (3-(benzo[d][1,3]dioxol-5-yl)-2-methylpropanal); METHYL NONYL KETONE (undecane-2-one); UNDECATRIENE ((3E,5Z)-undecac-1,3,5-triene); UNDECAVERTOL ((E)-4-methyldeca-3-en-5-ol); VANILLIN (4-hydroxy-3-methoxybenzaldehyde); VELVIONE ((Z)-cyclohexadeca-5-enone); VIOLET NITRILE ((2E,6Z)-nona-2,6-diennitrile); and YARA YARA (2-methoxynaphthalene).
[0021] All of the above-mentioned components not only meet at least one of the aforementioned biodegradability criteria, but have also been identified as suitable for encapsulation in terms of their physical and chemical properties, such as lipophilicity, molecular size, and reactivity to shell materials. Therefore, they provide a useful selection of fragrance components for easily and reliably providing more sustainable fragrance encapsulation.
[0022] In the encapsulated composition according to the present invention, each of the biodegradable components (one or more) is preferably present at a concentration equal to or less than the following maximum concentration:
[0023] 1-Phenylenone: 0.5 wt.-% 2,6,10-Trimethylundeca-9-enal: 1 wt.-% 2-(tert-butyl)cyclohexyl acetate: 50 wt.-% Hexane-1-ol: 10 wt.-% Decand: 10 wt.-% 2-Methyldecanal: 0.5 wt.-% Undeca-10-Enal: 2 wt.-% Undecanal: 5 wt.-% Dodecanal: 10 wt.-% 2-Methylundecanal: 50 wt.-% Hexanal: 5 wt.-% Octanal: 5 wt.-% 3,5,5-Trimethylhexanal: 0.5 wt.-% Nonanal: 5 wt.-% (E)-Undeca-9-Enal: 5 wt.-% Propa-2-enyl 2-(3-methylbutoxy)acetate: 5 wt.-% Propa-2-enylhexanoate: 5 wt.-% Propa-2-enyl-3-cyclohexylpropanoate: 10 wt.-% Propa-2-enylheptanoate: 10 wt.-% 3,8,8,11a-Tetramethyldodecahydro-1H-3,5a-Epoxynaphtho[2,1-c]oxepin: 2 wt.-% (Z)-Oxacycloheptadeca-10-en-2-one: 2 wt.-% (3aR,5aS,9aS,9bR)-3a,6,6,9a-tetramethyl-2,4,5,5a,7,8,9,9b-octahydro-1H-benzo[e][1]benzofuran: 2wt.-% Pentilbutanoate: 2 wt.-% (Z)-2-benzylideneheptanal: 5 wt.-% Pentyl 2-hydroxybenzoate: 50 wt.-% (E)-1-Methoxy-4-(propa-1-en-1-yl)benzene: 2 wt.-% 4-Methoxybenzyl acetate: 15 wt.-% 1-(3,3-dimethylcyclohexyl)ethyl formate: 0.5 wt.-% 4-Methoxybenzaldehyde: 5 wt.-% (E)-Methyl 2-((7-hydroxy-3,7-dimethyloctylidene)amino)benzoate: 0.2 wt.-% Benzaldehyde: 1 wt.-% Benzyl acetate: 10 wt.-% 4-Phenylbutan-2-one: 10 wt.-% Phenylethanol: 10 wt.-% Benzyl benzoate: 85 wt.-% Benzyl 3-phenylpropane-2-enoate: 2 wt.-% Benzyl 2-hydroxybenzoate: 75 wt.-% Octahydro-2H-chromen-2-one: 2 wt.-% (1S,2S,4S)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-ol: 10 wt.-% (2S,4S)-1,7,7-trimethylbicyclo[2.2.1]heptane-2-yl acetate: 35 wt.-% 3-(4-(tert-butyl)phenyl)propanal: 2 wt.-% Butyl acetate: 2 wt.-% 4-(tert-butyl)cyclohexyl acetate: 50 wt.-% (1S,4S)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-one: 25 wt.-% (5R)-2-methyl-5-propa-1-en-2-ylcyclohexa-2-en-1-one: 25 wt.-% (1R,6S,8aS)-6-methoxy-1,4,4,6-tetramethyloctahydro-1H-5,8a-methanoazulene: 5 wt.-% (E)-1-(2,6,6-trimethylcyclohexa-2-en-1-yl)hepta-1,6-dien-3-one: 0.5 wt.-% (E)-3-phenylpropa-2-en-1-ol: 10 wt.-% (2E)-3-phenylpropa-2-enal: 35 wt.-% (E)-3-phenylpropane-2-en-1-yl acetate: 0.5 wt.-% (Z)-Hexa-3-en-1-ol: 25 wt.-% (Z)-3-methyl-2-(penta-2-en-1-yl)cyclopenta-2-enone: 2 wt.-% (E)-3,7-dimethylocta-2,6-dienal: 5 wt.-% 3,7-Dimethylocta-6-enal: 1 wt.-% 3,7-Dimethylocta-6-en-1-ol: 25 wt.-% 3,7-Dimethylocta-6-en-1-ylacetate: 25 wt.-% 3,7-Dimethylocta-6-en-1-ylformate: 1 wt.-% 3,7-Dimethylocta-6-ennitrile: 10 wt.-% Dodecanenitrile: 10 wt.-% 4-Cyclohexyl-2-methylbutan-2-ol: 5 wt.-% 2-Hydroxy-3-methylcyclopenta-2-enone: 5 wt.-% (Z)-3-methylcyclotetradeca-5-enone: 5 wt.-% 2H-Cromen-2-one: 5 wt.-% 1-Methoxy-4-methylbenzene: 1 wt.-% 4-Isopropylbenzonitrile: 0.5 wt.-% 3-(4-isopropylphenyl)-2-methylpropanal: 5 wt.-% (E)-1-(2,6,6-trimethylcyclohexa-1,3-dien-1-yl)buta-2-en-1-one: 2.5 wt.-% (E)-1-(2,6,6-trimethylcyclohexa-2-en-1-yl)buta-2-en-1-one: 5 wt.-% 5-Hexyloxollan-2-one: 15 wt.-% (E)-Deca-4-Enal: 1 wt.-% 1-Methoxy-4-propylbenzene: 2 wt.-% 2,6-Dimethylocta-7-en-2-ol: 50 wt.-% 2-Methyl-1-phenylpropane-2-yl acetate: 75 wt.-% 2-Methyl-1-phenylpropane-2-ylbutanoate: 50 wt.-% 2,6-Dimethylheptan-2-ol: 5 wt.-% Oxydibenzene: 15 wt.-% (E)-Dodeca-2-Enal: 0.1 wt.-% (E)-3-methyl-5-(2,2,3-trimethylcyclopenta-3-en-1-yl)penta-4-en-2-ol: 5 wt.-% Ethylcyclohexylcarboxylate: 0.5 wt.-% Ethyl acetate: 10 wt.-% Ethyl 3-oxobutanoate: 2 wt.-% Ethyl 3-phenylpropane-2-enoate: 2 wt.-% Ethylhexanoate: 10 wt.-% (E)-3,7-dimethylnonona-1,6-dien-3-ol: 35 wt.-% 2-Ethyl-3-hydroxy-4H-pyran-4-one: 10 wt.-% Ethyl 2-methylbutanoate: 15 wt.-% Ethylheptanoate: 5 wt.-% 3-Ethoxy-4-hydroxybenzaldehyde: 10 wt.-% 1,4-Dioxacycloheptadecane-5,17-dione: 25 wt.-% (1s,4s)-1,3,3-trimethyl-2-oxabicyclo[2.2.2]octane: 25 wt.-% 4-Allyl-2-methoxyphenol: 5 wt.-% Methyl 2,4-dihydroxy-3,6-dimethylbenzoate: 2 wt.-% (1S,2R,4R)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-ol: 2 wt.-% 3-(4-methoxyphenyl)-2-methylpropanal: 2 wt.-% 3-(3-isopropylphenyl)butanal: 5 wt.-% Tetrahydro-4-methyl-2-(2-methylpropyl)-2H-pyran-4-ol: 10 wt.-% 2-(sec-butyl)cyclohexanone: 10 wt.-% 2-Methyldecanonitrile: 1 wt.-% 1-(5,5-dimethylcyclohexa-1-en-1-yl)penta-4-en-1-one: 5 wt.-% (E)-3,7-dimethylocta-2,6-dien-1-ol: 25 wt.-% (E)-3,7-dimethylocta-2,6-diene-1-yl acetate: 10 wt.-% (E)-6,10-dimethylundeca-5,9-dien-2-one: 1 wt.-% (E)-Oxacyclohexadeca-12-en-2-one: 15 wt.-% Methyl 3-oxo-2-pentylcyclopentane acetate: 75 wt.-% Benzo[d][1,3]dioxol-5-carbaldehyde: 10 wt.-% (E)-Hexa-2-Enal: 1 wt.-% (Z)-Hexa-3-en-1-ol: 15 wt.-% (Z)-Hexa-3-en-1-ylacetate: 15 wt.-% (Z)-Hexa-3-en-1-yl-2-methylpropanoate: 1 wt.-% (Z)-Hexa-3-en-1-yl-2-hydroxybenzoate: 15 wt.-% Hexyl acetate: 15 wt.-% (E)-2-Benzylidene Octanal: 25 wt.-% Hexyl 2-methylpropanoate: 5 wt.-% Hexyl 2-hydroxybenzoate: 85 wt.-% 7-Hydroxy-3,7-dimethyloctanal: 1 wt.-% 1H-Indole: 0.5 wt.-% (E)-4-(2,6,6-trimethylcyclohexa-1-en-1-yl)buta-3-en-2-one: 25 wt.-% (E)-4-(2,6,6-trimethylcyclohexa-2-en-1-yl)buta-3-en-2-one: 25 wt.-% 3-Methylbutyl acetate: 5 wt.-% (E)-2-Methoxy-4-(propa-1-en-1-yl)phenol: 1 wt.-% 2-Isopropyl-5-methylcyclohexanone: 1 wt.-% Isopropyl 2-methylbutanoate: 5 wt.-% (E)-3-methyl-4-(2,6,6-trimethylcyclohexa-2-en-1-yl)buta-3-en-2-one: 50 wt.-% (Z)-3-methyl-2-(penta-2-en-1-yl)cyclopenta-2-enone: 0.5 wt.-% 3-Butyl-5-methyltetrahydro-2H-pyran-4-yl acetate: 15 wt.-% 3-Pentyltetrahydro-2H-pyran-4-ylacetate: 50 wt.-% (Z)-Hexa-3-en-1-ylmethylcarbonate: 5 wt.-% 3-(4-(tert-butyl)phenyl)-2-methylpropanal: 25 wt.-% 1-Methyl-4-propa-1-en-2-ylcyclohexene: 85 wt.-% 2-(5-methyl-5-vinyltetrahydrofuran-2-yl)propan-2-ol: 1 wt.-% 3,7-Dimethylocta-1,6-dien-3-ol: 25 wt.-% 3,7-Dimethylocta-1,6-diene-3-yl acetate: 25 wt.-% (4E)-9-hydroxy-5,9-dimethyl-4-decanal: 10 wt.-% 3-Hydroxy-2-methyl-4H-pyran-4-one: 1 wt.-% Ethyl 2-methylpentanoate: 10 wt.-% (4-Isopropylcyclohexyl)methanol: 5 wt.-% 3-Methyl-5-phenylpentan-1-ol: 10 wt.-% 2,6-Dimethylhepta-5-enal: 2 wt.-% 2-Isopropyl-5-methylcyclohexanol: 85 wt.-% 2-Isopropyl-5-methylcyclohexanone: 2 wt.-% Methyl 2-aminobenzoate: 15 wt.-% Methylbenzoate: 1 wt.-% Methyl 3-phenylpropane-2-enoate: 10 wt.-% 2-Ethoxy-4-(methoxymethyl)phenol: 1 wt.-% Methyl 2-hexyl-3-oxocyclopentane-1-carboxylate: 5 wt.-% 6-Methylhepta-5-en-2-one: 5 wt.-% 8-Methyl-1-oxaspiro[4.5]decane-2-one: 2 wt.-% Methylnonano-2-inoate: 1 wt.-% Methyl 2-hydroxybenzoate: 1 wt.-% (Z)-3-methylcyclopentadeca-5-enone: 0.5 wt.-% 4-(4-methylpenta-3-en-1-yl)cyclohexa-3-encarbaldehyde: 2 wt.-% 7-Methyl-3-methyleneocta-1,6-diene: 0.5 wt.-% 2-Methylundecanoic acid: 0.5 wt.-% 2-(2-(4-methylcyclohexa-3-en-1-yl)propyl)cyclopentanone: 50 wt.-% (E)-methylnona-2-enoate: 2 wt.-% (2Z)-3,7-dimethylocta-2,6-dien-1-ol: 10 wt.-% (E)-3,7,11-trimethyldodeca-1,6,10-trien-3-ol: 5 wt.-% 2-Ethoxynaphthalene: 10 wt.-% (Z)-3,7-dimethylocta-2,6-diene-1-yl acetate: 0.5 wt.-% (E)-13-methyloxacyclopentadeca-10-en-2-one: 2 wt.-% (2E,6Z)-nona-2,6-dienal: 0.5wt.-% (2Z,6E)-2,6-nonadien-1-ol: 0.1 wt.-% 5-Pentyloxollan-2-one: 15 wt.-% (Z)-Nona-6-Enal: 0.5 wt.-% (Z)-non-6-en-1-ol: 0.5 wt.-% 2-(6,6-dimethylbicyclo[3.1.1]hepta-2-en-2-yl)ethyl acetate: 5 wt.-% 3-(4-(2-methylpropyl)-2-methylphenyl)propanal: 25 wt.-% Octane-2-on: 5 wt.-% 1-(2-naphthalenyl)-ethanone: 10 wt.-% (2-Methoxyethyl)benzene: 2 wt.-% 5-Heptyldihydrofuran-2(3H)-one: 25 wt.-% 3,7-Dimethyloctan-1-ol: 10 wt.-% 2-Cyclohexylhepta-1,6-diene-3-one: 2 wt.-% 2-(phenoxy)ethyl 2-methylpropanoate: 10 wt.-% 2-Phenyl-ethanal: 0.5 wt.-% 2-Phenylethyl acetate: 15 wt.-% 2-Phenylethanol: 25 wt.-% 2-Phenylethyl 2-methylpropanoate: 2 wt.-% 2-Phenylethyl 2-phenylacetate: 5 wt.-% 3-Phenylpropan-1-ol: 1 wt.-% 6,6-dimethyl-2-methylenebicyclo[3.1.1]heptane: 0.5 wt.-% 3-(6,6-dimethylbicyclo[3.1.1]hepta-2-en-2-yl)propanal: 0.1 wt.-% (2E,5E)-5,6,7-trimethylocta-2,5-dien-4-one: 2 wt.-% 1-Methyl-4-(4-methylpenta-3-en-1-yl)cyclohexa-3-encarbaldehyde: 2 wt.-% 3-Methylbuta-2-en-1-yl acetate: 10 wt.-% 4-(4-hydroxyphenyl)butan-2-one: 5 wt.-% 4-Methyl-2-(2-methylpropa-1-en-1-yl)tetrahydro-2H-pyran: 2 wt.-% 4-Methyl-2-phenyl-3,6-dihydro-2H-pyran: 2 wt.-% 3-Methyl-5-(2,2,3-trimethylcyclopenta-3-en-1-yl)pentan-2-ol: 10 wt.-% Ethyl(Z)-2-acetyl-4-methyltrideca-2-enoate: 0.5 wt.-% 4-(dodecylthio)-4-methylpentan-2-one: 0.5 wt.-% Cyclopentadecanone, Hexadecanolide: 20 wt.-% 1-Phenylethyl acetate: 5 wt.-% (E)-6-ethyl-3-methylocta-6-en-1-ol: 2 wt.-% (E)-2-((3,5-dimethylhexa-3-en-2-yl)oxy)-2-methylpropylcyclopropanecarboxylate: 5 wt.-% 1-Methyl-4-propane-2-ylcyclohexa-1,4-diene: 5 wt.-% 2-(4-methyl-1-cyclohexa-3-enyl)propan-2-ol: 1 wt.-% 2-(4-methylcyclohexa-3-en-1-yl)propan-2-ol: 25 wt.-% 1-Methyl-4-(propane-2-ylidene)cyclohexa-1-ene: 15 wt.-% 2-(4-methyl-1-cyclohexa-3-enyl)propane-2-yl acetate: 25 wt.-% 3,7-Dimethyloctan-3-ol: 50 wt.-% Oxacyclohexadecane-2-one: 10 wt.-% 2-Isopropyl-5-methylphenol: 10 wt.-% 1-(cyclopropylmethyl)-4-methoxybenzene: 10 wt.-% (E)-Trideca-2-ennitrile: 15 wt.-% 3-Phenylbutanal: 5 wt.-% 3-(benzo[d][1,3]dioxol-5-yl)-2-methylpropanal: 5 wt.-% Undecan-2-one: 0.1 wt.-% (3E,5Z)-Undeca-1,3,5-Triene: 0.1 wt.-% (E)-4-methyldeca-3-en-5-ol: 25 wt.-% 4-Hydroxy-3-methoxybenzaldehyde: 5 wt.-% (Z)-Cyclohexadeca-5-enone: 0.1 wt.-% 2E,6Z)-non-2,6-dienenitrile: 0.1 wt.-% 2-Methoxynaphthalene: 15 wt.-%
[0024] It was found that maintaining the concentration below the provided maximum value resulted in improved performance regarding the fragrance composition's suitability for olfactory perception and encapsulation.
[0025] In a preferred embodiment of the present invention, the fragrance composition includes ADOXAL (2,6,10-trimethylundecane-9-enal); AGRUMEX (2-(tert-butyl)cyclohexyl acetate); ALDEHYDE C 12 MNA (2-methylundecaneal); ALLYL AMYL GLYCOLATE (propa-2-enyl 2-(3-methylbutoxy) acetate); ALLYL CAPROATE (propa-2-enylhexanoate); ALLYL CYCLOHEXYL PROPIONATE (propa-2-enyl 3-cyclohexyl propanoate); ALLYL OENANTHATE (propa-2-enylheptanoate); AMYL BUTYRATE (pentylbutanoate); AMYL CINNAMIC ALDEHYDE ((Z)-2-benzylideneheptanal); APHERMATE (1-(3,3-dimethylcyclohexyl)ethyl formate); BENZYL ACETATE (benzyl acetate); BENZYL ACETONE (4-phenylbutan-2-one); BICYCLO NONALACTONE (octahydro-2H-chromen-2-one); BUTYL ACETATE (butyl acetate); BUTYL CYCLOHEXYL ACETATE PARA (4-(tert-butyl)cyclohexyl acetate); CETONE V((E)-1-(2,6,6-trimethylcyclohexa-2-en-1-yl)hepta-1,6-dien-3-one); DAMASCENONE((E)-1-(2,6,6-trimethylcyclohexa-1,3-dien-1-yl)buta-2-en-1-one); DAMASCONE ALPHA((E)-1-(2,6,6-trimethylcyclohexa-2-en-1-yl)buta-2-en-1-one); DECALACTONE GAMMA(5-hexyloxolan-2-one); DIMETHYL BENZYL CARBINYL ACETATE(2-methyl-1-phenylpropane-2-yl acetate); DIMETHYL BENZYL CARBINYL BUTYRATE (2-methyl-1-phenylpropane-2-ylbutanoate); ESTERLY (ethylcyclohexyl carboxylate); ETHYL ACETATE (ethyl acetate);ETHYL ACETOACETATE (Ethyl 3-oxobutanoate); ETHYL HEXANOATE (Ethyl hexanoate); ETHYL METHYL-2-BUTYRATE (Ethyl 2-methylbutanoate); ETHYL OENANTHATE (Ethyl heptanoate); FRUTONILE (2-methyldecanonitrile); GERANYL ACETATE ((E)-3,7-dimethylocta-2,6-dien-1-yl acetate); HEXENYL-3-CIS ACETATE ((Z)-hexa-3-en-1-yl acetate); HEXENYL-3-CIS ISOBUTYRATE ((Z)-hexa-3-en-1-yl 2-methylpropanoate); HEXYL ACETATE (Hexyl acetate); HEXYL ISOBUTYRATE (Hexyl 2-methylpropanoate); ISOAMYL ACETATE EXTRA (3-methylbutyl acetate); ISOPROPYL METHYL-2-BUTYRATE (isopropyl 2-methylbutanoate); JASMONYL (3-butyl-5-methyltetrahydro-2H-pyran-4-yl acetate); LIFFAROME ((Z)-hexa-3-en-1-ylmethylcarbonate); MANZANATE (ethyl 2-methylpentanoate); METHYL HEPTENONE (6-methylhepta-5-en-2-one); METHYL LAITONE (8-methyl-1-oxaspiro[4.5]decane-2-one); NECTARYL (2-(2-(4-methylcyclohexa-3-en-1-yl)propyl)cyclopentanone); NEOFOLIONE ((E)-methylnonano-2-enoate); NEROLIDOL ((E)-3,7,11-trimethyldodeca-1,6,10-trien-3-ol); NERYL ACETATE HC ((Z)-3,7-dimethylocta-2,6-dien-1-yl acetate); NONALACTONE GAMMA (5-pentyloxolan-2-one); ORANGER CRYSTALS (1-(2-naphthalenyl)-ethane); PEACH PURE (5-heptyldihydrofuran-2(3H)-one); PHENOXY ETHYL ISOBUTYRATE (2-(phenoxy)ethyl 2-methylpropanoate);The material comprises, preferably, PHENYL ETHYL ACETATE (2-phenylethyl acetate); POMAROSE ((2E,5E)-5,6,7-trimethylocta-2,5-dien-4-one); PRENYL ACETATE (3-methylbuta-2-en-1-yl acetate); RASPBERRY KETONE (4-(4-hydroxyphenyl)butan-2-one); SCENTAURUS CLEAN (ethyl(Z)-2-acetyl-4-methyltrideca-2-enoate); SCENTAURUS JUICY (4-(dodecylthio)-4-methylpentan-2-one); SYLKOLIDE ((E)-2-((3,5-dimethylhexa-3-en-2-yl)oxy)-2-methylpropylcyclopropane-carboxylate); and METHYL NONYL KETONE (undecane-2-one). These ingredients are particularly suitable for providing a fragrance with fruity characteristics.
[0026] In a preferred embodiment of the present invention, the fragrance composition includes: ACETOPHENONE EXTRA (1-phenylethanone); ALDEHYDE C 11 MOA (2-methyldecanal); ALDEHYDE C 11 UNDECYLENIC (unde-10-enal); ALDEHYDE ISO C 11 ((E)-unde-9-enal); AMYL CINNAMIC ALDEHYDE ((Z)-2-benzylidene heptanal); AMYL SALICYLATE (pentyl 2-hydroxybenzoate); AUBEPINE PARA-CRESOL (4-methoxybenzaldehyde); AURANTIOL PURE ((E)-methyl 2-((7-hydroxy-3,7-dimethyloctylidene)amino)benzoate); BENZALDEHYDE (benzaldehyde); BENZYL ACETATE EXTRA (benzyl acetate); BENZYL ACETONE (4-phenylbutan-2-one); BENZYL ALCOHOL EXTRA (phenylmethanol); BENZYL BENZOATE (benzyl benzoate); BENZYL CINNAMATE (benzyl 3-phenylpropane-2-enoate); BENZYL SALICYLATE (benzyl 2-hydroxybenzoate); BOURGEONAL (3-(4-(tert-butyl)phenyl)propanal); CETONE V ((E)-1-(2,6,6-trimethylcyclohexa-2-en-1-yl)hepta-1,6-dien-3-one); CIS-3-HEXENOL ((Z)-hexa-3-en-1-ol); CIS JASMONE ((Z)-3-methyl-2-(penta-2-en-1-yl)cyclopenta-2-enone); CITRONELLOL EXTRA(3,7-dimethylocta-6-en-1-ol); CITRONELLYL ACETATE(3,7-dimethylocta-6-en-1-yl acetate); CITRONELLYL FORMATE(3,7-dimethylocta-6-en-1-yl formate); CORANOL(4-cyclohexyl-2-methylbutan-2-ol); CRESYL METHYL ETHER PARA(1-methoxy-4-methylbenzene);CYCLAMEN ALDEHYDE EXTRA (3-(4-isopropylphenyl)-2-methylpropanal); DAMASCENONE GIV ((E)-1-(2,6,6-trimethylcyclohexa-1,3-dien-1-yl)buta-2-en-1-one); DAMASCONE ALPHA ((E)-1-(2,6,6-trimethylcyclohexa-2-en-1-yl)buta-2-en-1-one); DECALACTONE GAMMA (5-hexyloxolan-2-one); DECENAL-4-TRANS ((E)-deca-4-enal); DIHYDRO MYRCENOL (2,6-dimethylocta-7-en-2-ol); DIMETHYL BENZYL CARBINYL ACETATE (2-methyl-1-phenylpropane-2-yl acetate); DIMETHYL BENZYL CARBINYL BUTYRATE (2-methyl-1-phenylpropane-2-ylbutanoate); DIMETOL (2,6-dimethylheptan-2-ol); DIPHENYL OXIDE (oxydibenzene); ETHYL LINALOOL ((E)-3,7-dimethylnonano-1,6-dien-3-ol); FENNALDEHYDE (3-(4-methoxyphenyl)-2-methylpropanal); FLORHYDRAL (3-(3-isopropylphenyl)butanal); FLOROSA HC (tetrahydro-4-methyl-2-(2-methylpropyl)-2H-pyran-4-ol); GERANIOL ((E)-3,7-dimethylocta-2,6-dien-1-ol); GERANYL ACETATE SYNTHETIC ((E)-3,7-dimethylocta-2,6-dien-1-ylacetate); GERANYL ACETONE ((E)-6,10-dimethylundeca-5,9-dien-2-one); HEDIONE (methyl 3-oxo-2-pentylcyclopentane acetate); HELIOTROPINE CRYSTALS (benzo[d][1,3]dioxol-5-carbaldehyde); HEXENYL-3-CIS SALICYLATE ((Z)-hexa-3-en-1-yl 2-hydroxybenzoate); HEXYL CINNAMIC ALDEHYDE ((E)-2-benzylideneoctanal);HEXYL ISOBUTYRATE (Hexyl 2-methylpropanoate); HEXYL SALICYLATE (Hexyl 2-hydroxybenzoate); HYDROXYCITRONELLAL SYNTHETIC (7-hydroxy-3,7-dimethyloctanal); INDOLE PURE (1H-indole); IONONE BETA ((E)-4-(2,6,6-trimethylcyclohexa-1-en-1-yl)buta-3-en-2-one); IRISONE ALPHA ((E)-4-(2,6,6-trimethylcyclohexa-2-en-1-yl)buta-3-en-2-one); ISORALDEINE 70 ((E)-3-methyl-4-(2,6,6-trimethylcyclohexa-2-en-1-yl)buta-3-en-2-one); JASMONE CIS((Z)-3-methyl-2-(penta-2-en-1-yl)cyclopenta-2-enone); JASMONYL(3-butyl-5-methyltetrahydro-2H-pyran-4-yl acetate); JASMOPYRANE FORTE(3-pentyltetrahydro-2H-pyran-4-yl acetate); LILIAL(3-(4-(tert-butyl)phenyl)-2-methylpropanal); LINALOOL OXIDE(2-(5-methyl-5-vinyltetrahydrofuran-2-yl)propan-2-ol); LINALOOL SYNTHETIC(3,7-dimethylocta-1,6-dien-3-ol); LINALYL ACETATE SYNTHETIC (3,7-dimethylocta-1,6-diene-3-ylacetate); MAHONIAL ((4E)-9-hydroxy-5,9-dimethyl-4-decanal); MAYOL ((4-isopropylcyclohexyl)methanol); MEFROSOL (3-methyl-5-phenylpentan-1-ol); METHYL ANTHRANILATE EXTRA (methyl 2-aminobenzoate); METHYL BENZOATE (methyl benzoate); METHYL DIHYDRO ISOJASMONATE (methyl 2-hexyl-3-oxocyclopentan-1-carboxylate); METHYL SALICYLATE (methyl 2-hydroxybenzoate);MYRALDENE (4-(4-methylpenta-3-en-1-yl)cyclohexa-3-encarbaldehyde); NEROLEX ((2Z)-3,7-dimethylocta-2,6-dien-1-ol); NEROLIDOL SYNTHETIC ((E)-3,7,11-trimethyldodeca-1,6,10-trien-3-ol); NEROLINE CRYSTALS (2-ethoxynaphthalene); NERYL ACETATE HC((Z)-3,7-dimethylocta-2,6-dien-1-yl acetate); NONADIENAL((2E,6Z)-nona-2,6-dienal); NONADIENOL-2,6((2Z,6E)-2,6-nonadien-1-ol); NONENAL-6-CIS((Z)-nona-6-enal); NONENOL-6-CIS((Z)-nona-6-en-1-ol); NOPYL ACETATE(2-(6,6-dimethylbicyclo[3.1.1]hepta-2-en-2-yl)ethyl acetate); NYMPHEAL(3-(4-(2-methylpropyl)-2-methylphenyl)propanal); ORANGER CRYSTALS (1-(2-naphthalenyl)-ethanone); PANDANOL ((2-methoxyethyl)benzene); PELARGOL (3,7-dimethyloctan-1-ol); PHARAONE (2-cyclohexylhepta-1,6-dien-3-one); PHENOXY ETHYL ISOBUTYRATE (2-(phenoxy)ethyl 2-methylpropanoate); PHENYL ACETALDEHYDE (2-phenyl-ethanal); PHENYL ETHYL ACETATE (2-phenylethyl acetate); PHENYL ETHYL ALCOHOL (2-phenylethanol); PHENYL ETHYL ISOBUTYRATE (2-phenylethyl 2-methylpropanoate); PHENYL ETHYL PHENYL ACETATE (2-phenylethyl 2-phenyl acetate); PHENYL PROPYL ALCOHOL (3-phenylpropane-1-ol); POMAROSE ((2E,5E)-5,6,7-trimethylocta-2,5-dien-4-one); RASPBERRY KETONE (4-(4-hydroxyphenyl)butan-2-one);ROSE OXIDE CO(4-methyl-2-(2-methylpropane-1-en-1-yl)tetrahydro-2H-pyran); ROSYRANE SUPER(4-methyl-2-phenyl-3,6-dihydro-2H-pyran); STYRALLYL ACETATE(1-phenylethyl acetate); SUPER MUGUET((E)-6-ethyl-3-methylocta-6-en-1-ol); SYLKOLIDE((E)-2-((3,5-dimethylhexa-3-en-2-yl)oxy)-2-methylpropylcyclopropanecarboxylate); TERPINEOL PURE(2-(4-methylcyclohexa-3-en-1-yl)propane-2-ol); TERPINYL ACETATE(2-(4-methyl-1-cyclohexa-3-enyl)propane-2-yl acetate); TETRAHYDRO LINALOOL (3,7-dimethyloctan-3-ol); TRIFERNAL (3-phenylbutanal); TROPIONAL (3-(benzo[d][1,3]dioxol-5-yl)-2-methylpropanal); VIOLET NITRILE (2E,6Z)-nona-2,6-diennitrile); YARA YARA (2-methoxynaphthalene) are included, and preferably comprised of these components. These components are particularly suitable for providing a floral-characterized fragrance.
[0027] In a preferred embodiment of the present invention, the fragrance composition includes ADOXAL (2,6,10-trimethylundeca-9-enal); ALCOHOL C 6 HEXYLIC (Hexane-1-ol); ALDEHYDE C 10 DECYLIC (Decanal); ALDEHYDE C 11 MOA (2-methyldecanal); ALDEHYDE C 11 UNDECYLENIC (Undeca-10-enal); ALDEHYDE C 110 UNDECYLIC (Undecal); ALDEHYDE C 12 LAURIC (Dodecanal); ALDEHYDE C 12 MNA PURE (2-methylundecal); ALDEHYDE C 6 HEXYLIC FOOD GRADE (Hexane-1-al); ALDEHYDE C 8 OCTYLIC FOOD GRADE (Octanal); ALDEHYDE C 9 ISONONYLIC (3,5,5-trimethylhexanal); ALDEHYDE C 9 NONYLIC FOOD GRADE (nonanal); ALDEHYDE C 10 DECYLIC (decanal); ALDEHYDE C 11 UNDECYLENIC (undec-10-enal); ALDEHYDE C 12 MNA PURE (2-methylundecanal); ALDEHYDE ISO C 11 ((E)-undec-9-enal); CITRAL TECH ((E)-3,7-dimethylocta-2,6-dienal); CITRONELLAL SYNTHETIC (3,7-dimethylocta-6-enal); CITRONELLOL EXTRA (3,7-dimethylocta-6-en-1-ol); CITRONELLYL ACETATE (3,7-dimethylocta-6-en-1-yl acetate); CITRONELLYL FORMATE (3,7-dimethylocta-6-en-1-yl formate); CITRONELLYL NITRILE(3,7-dimethylocta-6-ennitrile);CLONAL(dodecanenitrile);DECENAL-4-TRANS((E)-deca-4-enal);DIHYDRO MYRCENOL(2,6-dimethylocta-7-en-2-ol);DODECENAL 10% / TEC((E)-dodeca-2-enal);The following components are preferably derived from FLORHYDRAL (3-(3-isopropylphenyl)butanal); HEXENAL-2-TRANS ((E)-hexa-2-enal); HYDROXYCITRONELLAL SYNTHETIC (7-hydroxy-3,7-dimethyloctanal); LIMONENE, LIMONENE LAEVO, LIMONENE DEXTRO (1-methyl-4-propa-1-en-2-ylcyclohexene); MELONAL (2,6-dimethylhepta-5-enal); NEROLEX ((2Z)-3,7-dimethylocta-2,6-dien-1-ol); and TERPINOLENE (1-methyl-4-(propan-2-ylidene)cyclohexa-1-ene). These components are particularly suitable for providing a citrus-aldehyde-characterized fragrance.
[0028] In a preferred embodiment of the present invention, the fragrance composition is: ALLYL AMYL GLYCOLATE (propa-2-enyl-2-(3-methylbutoxy)acetate); AMYL BUTYRATE (pentyl butanoate); ANETHOLE SYNTHETIC ((E)-1-methoxy-4-(propa-1-en-1-yl)benzene); ANISYL ACETATE (4-methoxybenzyl acetate); APHERMATE (1-(3,3-dimethylcyclohexyl)ethyl formate); BORNEOL CRYSTALS ((1S,2S,4S)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-ol); BORNYL ACETATE LIQUID ((2S,4S)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl acetate); CAMPHOR SYNTHETIC((1S,4S)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-one); CARVONE LAEVO((5R)-2-methyl-5-propa-1-en-2-ylcyclohexa-2-en-1-one); CIS-3-HEXENOL((Z)-hexa-3-en-1-ol); DIHYDRO MYRCENOL(2,6-dimethylocta-7-en-2-ol); DIMETOL(2,6-dimethylheptan-2-ol); DIPHENYL OXIDE(oxydibenzene); EUCALYPTOL NATURAL((1s,4s)-1,3,3-trimethyl-2-oxabicyclo[2.2.2]octane); EUGENOL(4-allyl-2-methoxyphenol); FENCHYL ALCOHOL((1S,2R,4R)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-ol);FENNALDEHYDE(3-(4-methoxyphenyl)-2-methylpropanal);FRESKOMENTHE(2-(sec-butyl)cyclohexanone);GALBANONE PURE(1-(5,5-dimethylcyclohexa-1-en-1-yl)penta-4-en-1-one);HEXENOL-3-CIS((Z)-hexa-3-en-1-ol);HEXENYL-3-CIS ACETATE((Z)-hexa-3-en-1-yl acetate);HEXENYL-3-CIS ISOBUTYRATE ((Z)-Hexa-3-en-1-yl 2-methylpropanoate); HEXENYL-3-CIS SALICYLATE ((Z)-Hexa-3-en-1-yl 2-hydroxybenzoate); HEXYL ISOBUTYRATE (Hexyl 2-methylpropanoate); ISOMENTHONE DL (2-Isopropyl-5-methylcyclohexanone); ISOPROPYL METHYL-2-BUTYRATE (Isopropyl 2-methylbutanoate); JASMONE CIS ((Z)-3-methyl-2-(penta-2-en-1-yl)cyclopenta-2-enone); LIFFAROME GIV ((Z)-Hexa-3-en-1-ylmethylcarbonate); LINALYL ACETATE SYNTHETIC (3,7-dimethylocta-1,6-diene-3-ylacetate); MANZANATE (ethyl 2-methylpentanoate); MENTHOL, MENTHOL LAEVO, MENTHOL RACEMIC (2-isopropyl-5-methylcyclohexanol); MENTHONE, ISOMENTHONE, MENTHONE LAEVO, MENTHONE RACEMIC (2-isopropyl-5-methylcyclohexanone); METHYL OCTYNE CARBONATE (methylnonano-2-inoate); MYRCENE 90(7-methyl-3-methyleneocta-1,6-diene); NEOFOLIONE((E)-methylnona-2-enoate); NONADIENAL((2E,6Z)-nona-2,6-dienal); NONADIENOL-2,6((2Z,6E)-2,6-nonadien-1-ol); NONALACTONE GAMMA(5-pentyloxolan-2-one); NONENAL-6-CIS((Z)-nona-6-enal); NONENOL-6-CIS((Z)-nona-6-en-1-ol); NOPYL ACETATE(2-(6,6-dimethylbicyclo[3.1.1]hepta-2-en-2-yl)ethyl acetate); PANDANOL((2-methoxyethyl)benzene); PINENE BETA(6,6-dimethyl-2-methylenebicyclo[3.1.1]heptane);PINOACETALDEHYDE(3-(6,6-dimethylbicyclo[3.1.1]hepta-2-en-2-yl)propanal); TERPINEOL ALPHA(2-(4-methyl-1-cyclohexa-3-enyl)propan-2-ol); TERPINEOL PURE(2-(4-methylcyclohexa-3-en-1-yl)propan-2-ol); TERPINOLENE(1-methyl-4-(propan-2-ylidene)cyclohexa-1-ene); TERPINYL The composition includes, and preferably comprises, ACETATE (2-(4-methyl-1-cyclohexa-3-enyl)propane-2-yl acetate); THYMOL (2-isopropyl-5-methylphenol); TOSCANOL (1-(cyclopropylmethyl)-4-methoxybenzene); TRIDECENE-2-NITRILE ((E)-trideca-2-ennitrile); UNDECATRIENE ((3E,5Z)-undeca-1,3,5-triene); UNDECAVERTOL ((E)-4-methyldeca-3-en-5-ol); VANILLIN (4-hydroxy-3-methoxybenzaldehyde); and VIOLET NITRILE (2E,6Z)-nona-2,6-diennitrile). These components are particularly suitable for providing a fragrance with green aromatic characteristics.
[0029] Furthermore, each of the biodegradable components(s) described herein may be present at a minimum concentration equal to or higher than 0.01 wt.-%, preferably 0.02 wt.-%, more preferably 0.05 wt.-%, even more preferably 0.1 wt.-%, and even more preferably 0.5 wt.-%.
[0030] The water-soluble matrix may include at least one material selected from the group consisting of starch, particularly water-soluble modified starch, maltodextrin, mannitol, chitosan, acacia gum, alginate, cellulose, pectin, gelatin, polyvinyl alcohol, and mixtures thereof. The resulting flavor encapsulations are simple and cost-effective in production. Furthermore, they are prepared from naturally based materials that are non-toxic and biodegradable. Such encapsulations therefore have increased consumer appeal.
[0031] When the starch is a water-soluble modified starch, such starch can be made from raw starch or pregelatinized starch. It can be derived from tubers, legumes, grains and cereals, such as corn starch, wheat starch, rice starch, waxy corn starch, oat starch, cassava starch, waxy barley starch, glutinous rice starch, sweet rice starch, amioca starch, potato starch, tapioca starch, and mixtures thereof.
[0032] Water-soluble modified starches can be selected from the group consisting of bleached starch, hydroxypropyl starch, hydroxypropyl distarch phosphate, hydroxypropyl distarch glycerol, acetylated distarch phosphate, acetic acid starch esterified with acetic anhydride, acetic acid starch esterified with vinyl acetate, acetylated adipic acid distarch, acetylated distarch glycerol, sodium octenyl succinate starch, and mixtures thereof.
[0033] Water-soluble modified starches possess emulsifying and emulsion-stabilizing properties. Due to the hydrophobic characteristics of the starch modifier, they have the ability to encapsulate fragrance droplets in the form of oil-in-water emulsions. The modified starches described herein offer numerous advantages, including high emulsifying and encapsulating performance, low viscosity even with high solids content, and excellent oxidation resistance, ensuring good preservation of fragrances and / or cosmetics and stabilization of highly sensitive ingredients.
[0034] When the water-soluble matrix contains water-soluble modified starch, it may additionally contain materials selected from the group consisting of maltodextrin, mannitol, and mixtures thereof. Both maltodextrin and mannitol increase the glass transition temperature of the matrix. Furthermore, maltodextrin is also a film-forming agent.
[0035] Maltodextrins are characterized by their dextrin equivalents (DE). The higher the DE, the lower the molecular weight of the maltodextrin. In the context of this invention, maltodextrins having different DEs may be combined to provide optimized encapsulation properties. Without being bound by any theory, it is hypothesized that a mixture of low-DE and high-DE maltodextrins would improve the filling of water-soluble matrices.
[0036] In addition to the materials described herein, the water-soluble matrix may further contain hemicellulose. In the context of the present invention, the term "hemicellulose" should be understood as a polysaccharide selected from the group consisting of glucans, in particular xyloglucan; mannans, in particular glucomannan; and xylans, in particular arabinoxylan and glucuronoxylan.
[0037] The addition of hemicellulose to water-soluble matrices, particularly starch matrices, has been found to modify the matrix by improving its fragrance release properties under moisture and mechanical (e.g., friction) activation.
[0038] The hemicellulose is preferably xyloglucan, particularly xyloglucan obtained from tamarind seeds. Xyloglucan is the most abundant hemicellulose in the primary wall of non-grass plants, often accounting for 20 wt.-% of the dry mass of the wall. Xyloglucan has a backbone composed of 1,4-linked β-D-glucose residues. Up to 75% of the backbone residues, C6 is substituted with monosaccharide, disaccharide, or trisaccharide side chains. Preferably, the hemicellulose is xyloglucan that can be obtained from tamarind seeds, particularly xyloglucan obtained from tamarind seeds, also known as "tamarind kernel powder" or "tamarind gum". In tamarind gum, the side chain consists of one or two α-D-xylopyranosyl units, optionally capped with β-D-galactopyranosyl, α-L-arabinofuranosyl, or β-D-xylopyranosyl.
[0039] In the context of the present invention, the fragrance composition may be encapsulated, at least partially, in a core-shell microcapsule comprising a core and a shell surrounding the core.
[0040] Such compositions enable fragrance release through mechanical action or moisture-induced activation, for example, in deodorant or antiperspirant applications. However, such compositions are also particularly useful when employed as fragrance delivery means in consumer products (for example, laundry detergents) that require core-shell microcapsules to adhere to the substrate to which they are applied in order to provide optimal perfume benefits.
[0041] In a specific embodiment of the present invention, the fragrance composition may be completely encapsulated in core-shell microcapsules. Such powder encapsulated materials are expected to emit virtually no odor when at rest or exposed to moisture, and to release an odor boost when subjected to mechanical stress.
[0042] When a fragrance composition is partially encapsulated within a core-shell microcapsule, the composition of the fragrance components encapsulated within the core-shell microcapsule and the composition of the fragrance components not encapsulated within the core-shell microcapsule can be the same or different. This results in a regulated release of the same or different scent impression, depending on whether the encapsulated material is exposed to moisture or mechanical stress. In particular, the sequential release of fragrance components can be conceived.
[0043] In the context of the present invention, the shell of a core-shell microcapsule can be made of a biodegradable or non-biodegradable material. In particular, the shell of a core-shell microcapsule may include a polymer selected from the group consisting of melamine-formaldehyde polymer, urea-formaldehyde polymer, polyurea, polyurethane, polyamide, polyacrylate, polycarbonate, and combinations thereof.
[0044] Core-shell microcapsules with a melamine-formaldehyde polymer shell have proven particularly suitable for encapsulating fragrances. They are described in the prior art, specifically in WO 2008 / 098387 A1, WO 2016 / 207180 A1, and WO 2017 / 001672 A1.
[0045] Core-shell microcapsules with polyurea or polyurethane polymer shells have also been successfully used for fragrance encapsulation. They have the advantage of addressing consumer concerns regarding residual formaldehyde in the composition. Such capsules are also described in the prior art, for example, in WO 2019 / 174978 A1.
[0046] Core-shell microcapsules having a shell of polyacrylate, i.e., one or more monoethylene unsaturated and / or polyethylene unsaturated monomers (one or more), which are the polymerized form, have also been successfully used for fragrance encapsulation. Such capsules are described in the prior art, for example, in WO 2013 / 111912 A1 or WO 2014 / 032920 A1.
[0047] As a further alternative, the shell of the core-shell microcapsule may include a polymer stabilizer formed by a combination of a polymer surfactant and at least one aminosilane.
[0048] The shell may subsequently contain polysaccharides, preferably polysaccharides containing beta(1→4) linked monosaccharide units, and more preferably cellulose derivatives, selected from the group consisting particularly of hydroxyethylcellulose, hydroxypropylmethylcellulose, cellulose acetate, and carboxymethylcellulose, preferably hydroxyethylcellulose.
[0049] The term "polymer surfactant" refers to a polymer, or a mixture containing at least one polymer, that, when dissolved in either or both of an oil phase and / or aqueous phase, has the property of reducing the interfacial tension between the oil phase and / or aqueous phase. This ability to reduce interfacial tension is called "surface activity."
[0050] In this context, the term "formed by combination" means that a polymer surfactant and at least one aminosilane come into contact with each other to form a polymer stabilizer. Without being bound by any theory, this formation may be the result of interactions such as dispersion forces, electrostatic forces, or hydrogen bonding between the polymer surfactant and at least one aminosilane. However, in a strict sense, chemical reactions for forming covalent bonds are also encompassed by this term.
[0051] In other words, a polymer stabilizer can be considered as an aggregate comprising a portion derived from a polymer surfactant and a portion derived from at least one aminosilane.
[0052] Polymer surfactants are either soluble or dispersible in the aqueous phase or in water, respectively. This means that individual polymer surfactant polymers are substantially separated from each other in these liquids. The resulting system appears clear or hazy to the human eye.
[0053] Polymer stabilizers can be a factor in balancing core-shell microcapsule stability with respect to both fragrance leakage during storage and fragrance release under use conditions. In particular, the importance of providing additional stabilization of the oil-water interface has been recognized. Polymer stabilizers thus provide a stable platform, which allows for the formation of encapsulated fragrance compositions for the addition of additional shell material and / or shell precursors. More specifically, the addition of polysaccharides, preferably polysaccharides containing beta(1→4) linked monosaccharide units, and more preferably cellulose derivatives, results in highly sustainable microcapsules with an excellent release profile.
[0054] Polysaccharides may be deposited on the outer surface of the core-shell microcapsule shell formed by a polymer stabilizer. This results in a multilayer shell having at least one layer of polymer stabilizer and one layer of polysaccharides. The impermeability of the encapsulated shell can be improved by increasing the amount of capsule material.
[0055] To avoid ambiguity, this aspect of the present invention is not meant to be limited to a core-shell microcapsule shell having distinct, discontinuous layers, although this is one viable embodiment. More specifically, the layers can be loose and discontinuous. On the other hand, and in other extreme examples, the shell can even be essentially uniform.
[0056] Polysaccharides can react with unreacted groups of polymer stabilizers and increase the density of crosslinked core-shell microcapsules. However, polysaccharides can also interact with polymer stabilizers through physical forces, physical interactions, such as hydrogen bonding, ionic interactions, hydrophobic interactions, or electron transfer interactions.
[0057] Core-shell microcapsules containing additional polysaccharides can be further stabilized with a stabilizer. Preferably, the stabilizer contains at least two carboxylic acid groups. More preferably, the stabilizer is selected from the group consisting of citric acid, benzene-1,3,5-tricarboxylic acid, 2,5-franzicarboxylic acid, itaconic acid, poly(itaconic acid), and combinations thereof.
[0058] In specific embodiments of the present invention, the polymer surfactant comprises, in particular, a polysaccharide containing a carboxylic acid group. It has been found that combining such a polymer surfactant with at least one aminosilane results in the formation of a polymer stabilizer that is more sustainable than stabilizers known in the prior art, particularly from the standpoint of environmental and resource conservation. Without being bound by any theory, it is inferred that the carboxylic acid group reacts with at least one aminosilane in the manner described herein.
[0059] Polysaccharides containing carboxylic acid groups may contain uronic acid units, particularly hexuronic acid units. Polysaccharides having uronic acid units, especially hexuronic acid units, are widely available in nature.
[0060] The hexuronic acid unit is selected from the group consisting of galacturonic acid units, glucuronic acid units, and in particular 4-O-methyl-glucuronic acid units, glucuronic acid units, and mannuronic acid units.
[0061] Polysaccharides containing carboxylic acid groups may be branched. Branched polysaccharides containing carboxylic acid groups have the advantage of forming a more compact network than linear polysaccharides, which is advantageous for the impermeability of the encapsulation shell, resulting in reduced leakage and higher encapsulation efficiency.
[0062] The polymer surfactant can be selected from pectin, gum arabic, and alginic acid. As shown in the examples, these polysaccharides provide the most suitable combination of solubility, viscosity, and interfacial activity, making the microcapsules according to the present invention particularly good in terms of handling, storage stability, and olfactory performance. The polymer surfactant may also be hyaluronic acid.
[0063] The aminosilane used in the formation of polymer stabilizers can be selected from compounds represented by formula (I). [ka]
[0064] In the above equation (I), R 1 , R 2 and R 3 Each is independently a C1-C4 linear or branched alkyl or alkenyl residue, particularly methyl or ethyl, and R 4 This includes amine functional groups, particularly primary, secondary, or tertiary amines, C1-C 12 Preferably, these are C1-C4, linear or branched alkyl or alkenyl residues.
[0065] When the functional group is a primary amine, it can be considered a terminal primary amine. 4is then preferably a C1-C8, even more preferably a C1-C4, linear terminal primary aminoalkyl residue. Specific amino silanes of this category are selected from the group consisting of aminomethyltriethoxysilane, 2-aminoethyltriethoxysilane, 3-aminopropyltriethoxysilane, 4-aminobutyltri-ethoxysilane, 5-aminopentyltriethoxysilane, 6-aminohexyltriethoxysilane, 7-aminoheptyltriethoxysilane, and 8-aminooctyltriethoxysilane.
[0066] Without being bound by any theory, it is speculated that the silane groups polycondense with each other to form a silica network at the liquid-liquid interface, further stabilizing this interface.
[0067] The amino silane can be a bifunctional amino silane. "Bifunctional amino silane" means a molecule containing at least one amino group and two residues, each of these residues having at least one alkoxysilane moiety.
[0068] In a specific embodiment of the present invention, at least one bifunctional amino silane has formula (II). (O-R 4 ) (3-f) (R 3 ) f Si-R 2 -X-R 2 -Si(O-R 4 ) (3-f) (R 3 ) f Formula (II)
[0069] In the above formula (II), X is -NR 1 -, -NR 1 -CH2-NR 1 -, -NR 1 -CH2-CH-2-NR 1 -, -NR 1 -CO-NR 1 -, or
Chemical formula
[0070] Bipod-type aminosilanes are particularly advantageous compared to conventional silanes for forming a stable oil-water interface. Examples of bipedal aminosilanes, but not limited to these, include bis(3-(triethoxysilyl)propyl)amine, N,N'-bis(3-(trimethoxysilyl)propyl)urea, bis(3-(methyldiethoxysilyl)propyl)amine, N,N'-bis(3-(trimethoxysilyl)propyl)ethane-1,2-diamine, bis(3-(methyldimethoxysilyl)propyl)-N-methylamine, and N,N'-bis(3-(triethoxysilyl)propyl)piperazine.
[0071] The bipoded aminosilane can be a secondary aminosilane. Using a secondary bipoded aminosilane instead of a primary aminosilane reduces the reactivity of the polymer stabilizer with respect to electrophilic species, particularly aldehydes. Therefore, encapsulants containing high levels of aldehydes can be encapsulated with a reduced tendency for harmful interactions between the core-forming and shell-forming materials.
[0072] The secondary bilegged aminosilane can be a bis(3-(triethoxysilyl)propyl)amine. This particular secondary aminosilane has the advantage of releasing ethanol instead of the more toxic and less desirable methanol during the polycondensation of the ethoxysilane group.
[0073] Other aminosilanes may be used in combination with the aforementioned bipodial aminosilanes, particularly the aminosilanes described herein. The weight ratio of aminosilane to polymer surfactant can be 0.1 to 1.1, particularly 0.2 to 0.9, and more specifically 0.3 to 0.7, for example, 0.5.
[0074] Polymer stabilizers can be formed by combining polymer surfactants with at least one aminosilane and further polyfunctional isocyanates. Polyfunctional isocyanates can densify the arrangement of polymer surfactants at the oil / water interface. Without being bound by any theory, it is hypothesized that polyfunctional isocyanates crosslink both aminosilanes and polysaccharides by forming polyurea and polyurethane bonds.
[0075] The polyfunctional isocyanates may be selected from alkyl, alicyclic, aromatic, alkyl-aromatic, and anionic modified polyfunctional isocyanates having two or more (e.g., 3, 4, 5, etc.) isocyanate groups in the molecule.
[0076] Preferably, at least one polyfunctional isocyanate is an aromatic or alkyl-aromatic polyfunctional isocyanate, the alkyl-aromatic polyfunctional isocyanate preferably having a methyl isocyanate group bonded to the aromatic ring. Alkyl-aromatic polyfunctional isocyanates substituted with both aromatic and methyl isocyanates exhibit superior reactivity compared to alkyl and alicyclic polyfunctional isocyanates. Among these, 2-ethylpropane-1,2,3-triyltris((3-(isocyanatemethyl)phenyl)carbamate is particularly preferred because its tripod-like properties are advantageous for the formation of intermolecular crosslinks, and its intermediate reactivity is advantageous for network uniformity. This alkyl-aromatic polyfunctional isocyanate is commercially available from Mitsui under the trademark Takenate D-100 N, or from Covestro under the trademark Desmodur® Quix175.
[0077] In a particularly preferred embodiment of the present invention, the polymer stabilizer is formed by a combination of pectin with bis(3-(triethoxysilyl)propyl)amine. Preferably, the polymer stabilizer is formed by a combination of pectin with bis(3-(triethoxysilyl)propyl)amine and 2-ethylpropane-1,2,3-triyltris((3-(isocyanatemethyl)phenyl)carbamate). These combinations of natural polymer surfactants and bipodial secondary aminosilanes provide particularly advantageous interfacial stability and release properties. The stabilized interface is sufficiently impermeable to favorably encapsulate at least one beneficial agent contained in the core. The polymer stabilizer effectively forms a shell that encapsulates at least one fragrance component contained in the core.
[0078] As a further alternative, the core-shell microcapsule shell may include a complex formed of at least one protein and at least one polysaccharide. Such core-shell microcapsules have proven suitable for fragrance encapsulation and are described in the prior art, for example, in WO 1996 / 020612 A1, WO 2001 / 03825 A1 or WO 2015 / 150370 A1.
[0079] In a preferred embodiment of the present invention, the core-shell microcapsule shell is formed by crosslinking at least one protein with a first crosslinking agent to form a simple coacervate, followed by the addition of at least one polysaccharide to form a complex coacervate. A "coacervate" refers to a state where droplets rich in polymer electrolytes coexist with a continuous aqueous phase that is poor in polymer electrolytes. The droplets aggregate at the interface, forming an interfacial layer.
[0080] In this context, coacervate droplets aggregate at the interface between the core composition and the aqueous phase. As a result, a stable core composition emulsion is formed in water, containing multiple core composition droplets, each surrounded by coacervate droplets. These stabilize the emulsion by preventing the droplets from coalescing. These stabilized droplets act as templates, during which microencapsulation occurs.
[0081] In this context, "simple coacervation" refers to the formation of an interfacial layer containing a single polymer electrolyte. "Composite coacervation" refers to the formation of an interfacial layer containing a mixture of polymer electrolytes. The phenomenon of simple or complex coacervation can be observed with an optical microscope, where it is indicated by the appearance of a ring around a droplet of the core composition. This ring consists of the aforementioned polymer electrolyte-rich phase and has a different refractive index than the surrounding aqueous phase.
[0082] Coaservation of a single polymer electrolyte is generally induced by bringing the polymer electrolyte closer to its isoelectric point (meaning the point where the pure charge of the polymer electrolyte is zero or close to zero). This may be achieved by changing the salt concentration, or, in the case of polymer electrolytes such as proteins, by changing the pH of the medium. It was found that simple coacervation may also be induced by protein crosslinking at the core composition / water interface.
[0083] More specifically, it was found that a simple cross-linked protein coacervate is first formed at the core composition / aqueous phase interface, followed by the formation of a complex coacervation of this cross-linked protein with a second polyelectrolyte, i.e., at least one polysaccharide, resulting in the formation of a shell with enhanced impermeability. In particular, the shell exhibits enhanced impermeability to low molecular weight materials, i.e., materials with a molecular weight lower than 250 g / mol, such as fragrance components.
[0084] Furthermore, compared to conventional coacervate core-shell microcapsules, capsules obtained by this process exhibit increased stability in powder formulations.
[0085] Furthermore, the applicant has found that by implementing the aforementioned process, it is feasible to better control the size of microcapsules compared to conventional composite coacervation. In particular, it became feasible to obtain microcapsules with a size of less than 75 μm. This is much smaller than the microcapsule sizes reported in the prior art. This is far more advantageous because microcapsules with a size of less than 75 μm are known to deposit better on substrates during rinse-off applications than larger microcapsules.
[0086] Proteins particularly suitable for this aspect of the present invention include gelatin, whey protein, pea protein, soy protein, casein, and albumin, with bovine serum albumin being an example.
[0087] In a preferred embodiment, at least one protein is gelatin, preferably type B gelatin. Type B gelatin can be obtained from the alkali treatment of collagen and is well known for its ability to form complexes with anionic polyelectrolytes such as negatively charged polysaccharides under weakly acidic conditions.
[0088] Gelatin is typically characterized by its so-called "bloom strength." In this context, bloom strength refers to the rigidity of a gelatin film, according to Chapter 2.1 of the Official Procedures of the Gelatin Manufacturers Institute of America, Inc., 2019 revised edition. According to this procedure, the bloom strength, as expressed in bloom, is equal to the weight in grams required to move a standardized plunger with a diameter of 12.5 mm vertically to a depth of 4 mm into a gelatin gel prepared under controlled conditions, i.e., in a standardized jar, by dissolving 6.67 wt% gelatin in deionized water at 60°C and allowing the gel to form at 10°C for 17 hours. A higher weight indicates a higher bloom strength of the gelatin used to prepare the test gel.
[0089] In a preferred embodiment, the type B gelatin has a bloom strength of 200–250. If the bloom strength is too low, the gel is mechanically weak, and the resulting coacervate may not form an independent layer of gelatin-rich phase around the core composition. If the bloom strength is too high, then the resulting coacervate and gelatin may be too brittle.
[0090] Type B gelatin can be obtained from fish because fish gelatin is more readily accepted by consumers than beef or pork gelatin, mainly due to health concerns, social background, or religious reasons. Alternatively, the protein can be vegetable protein, particularly pea protein and / or soy protein, which has the advantage of being vegan.
[0091] In a preferred embodiment, the first crosslinking agent is a trifunctional alkyl aromatic isocyanate. As stated previously, and without being bound by any theory, the applicant believes that alkyl aromatic isocyanate groups have the advantage of having intermediate reactivity compared to highly reactive aromatic isocyanates and less reactive aliphatic isocyanates.
[0092] More preferably, the trifunctional alkyl aromatic isocyanate is an adduct of 2-ethylpropane-1,2,3-triol or 2-ethyl-2-(hydroxymethyl)propane-1,3-diol with 1-isocyanate-2-(isocyanatemethyl)benzene, 1-isocyanate-3-(isocyanatemethyl)benzene and / or 1-isocyanate-4-(isocyanatemethyl)benzene.
[0093] In a specifically preferred embodiment, the trifunctional aromatic aliphatic isocyanate is an adduct of 2-ethylpropane-1,2,3-triol and 1-isocyanate-3-(isocyanatemethyl)benzene. The adduct of 2-ethylpropane-1,2,3-triol and 1-isocyanate-3-(isocyanatemethyl)benzene is commercially available under the trademarks Takenate D110-N (ex Mitsui Chemicals) or Quix 175 (ex Covestro).
[0094] In connection with this aspect of the present invention, at least one polysaccharide, preferably containing a carboxylic acid group, is used. Polysaccharides containing a carboxylic acid group are particularly suitable for complex coacervation with proteins, and especially with type B gelatin. This is because adjusting the pH adjusts the net charge of these polysaccharides, promoting complex formation with amphoteric proteins. Complex formation occurs at a pH where the protein as a whole has a positive charge, while the polysaccharide as a whole has a negative charge, resulting in a neutral overall charge for the complex. These polysaccharides include native polysaccharides and modified polysaccharides from nature. Monovalent alkali metal salts of these polysaccharides can also be used.
[0095] In particular, at least one sugar is selected from the group consisting of carboxymethylcellulose, gum arabic, alginic acid, pectin, hyaluronic acid, xanthan gum, gellan gum, and salts thereof with monovalent alkali metals. Carboxymethylcellulose, sodium carboxymethylcellulose, and gum arabic are particularly preferred.
[0096] In a preferred embodiment, the impermeability and stability of the core-shell microcapsule shell may be further improved by crosslinking the composite coacervate with a second crosslinking agent. In a particularly preferred embodiment, the second crosslinking agent is a bifunctional aldehyde selected from the group consisting of succinaldehyde, glutaraldehyde, glyoxal, benzene-1,2-dialdehyde, benzene-1,3-dialdehyde, benzene-1,4-dialdehyde, piperazine-N,N-dialdehyde, and 2,2'-bipyridyl-5,5'-dialdehyde. Bifunctional aldehydes are known as effective crosslinking agents for proteins.
[0097] In this aspect of the present invention, the weight ratio of the first crosslinking agent, in particular a trifunctional aromatic aliphatic isocyanate, to at least one protein, in particular gelatin, can be 0.08 to 1.2, preferably 0.12 to 0.8, more preferably 0.16 to 0.6, and even more preferably 0.2 to 0.4. With such a weight ratio of the first crosslinking agent to the protein, good stability of the microcapsules, particularly with respect to leakage, can be achieved while simultaneously ensuring biodegradability.
[0098] The weight ratio of polysaccharides to proteins typically depends on the properties of the polysaccharides. Without being bound by any theory, this weight ratio is considered to depend on the degree of substitution of the polysaccharide, particularly at the carboxyl or carboxylate groups, where applicable. Preferably, the weight ratio between at least one polysaccharide and at least one protein is 0.05 to 0.5, preferably 0.08 to 0.2.
[0099] In a preferred embodiment of the present invention, the median volume diameter Dv(50) of the multiple core-shell microcapsules is 1 to 100 μm, preferably 5 to 75 μm, more preferably 8 to 60 μm, and even more preferably 10 to 30 μm. Microcapsules having a median volume diameter in the range of 10 to 30 μm exhibit optimal deposition on various substrates such as fabrics and hair.
[0100] If desired, core-shell microcapsules may be coated with a functional coating. The functional coating may coat the microcapsule shell entirely or only partially. Whether the functional coating is charged or uncharged, its primary purpose is to achieve desired effects, such as altering the surface properties of the microcapsules and promoting the deposition of microcapsules on treatment surfaces such as fabrics, human skin, or hair. The functional coating may be applied retrospectively to already formed core-shell microcapsules, or it may be physically incorporated into the microcapsule shell during shell formation. They may be attached to the shell by physical forces, physical interactions such as hydrogen bonding, ionic interactions, hydrophobic interactions, or electron mobile phase interactions, or they may be covalently bonded to the shell.
[0101] In the encapsulated composition according to the present invention, the proportion of the fragrance composition may be 10 to 50 wt.-%, preferably 20 to 47.5 wt.-%, and more preferably 30 to 45 wt.-%, based on the total weight of the encapsulated composition. At the same time, the proportion of the water-soluble matrix may be 30 to 90 wt.-%, preferably 35 to 80 wt.-%, and more preferably 40 to 70 wt.-%, based on the total weight of the encapsulated composition. Under these conditions, there is an optimal balance between encapsulation efficiency, storage stability, and olfactory performance.
[0102] If the water-soluble matrix contains hemicellulose, the proportion of hemicellulose can be 0.02 to 20 wt.-%, preferably 0.1 to 10 wt.-%, and more preferably 0.5 to 5 wt.-%, relative to the total weight of the encapsulated composition.
[0103] When the fragrance composition is encapsulated in core-shell microcapsules, the proportion of the fragrance composition encapsulated in the core-shell microcapsules can be 5 to 30 wt.-%, preferably 7 to 25 wt.-%, and more preferably 10 to 20 wt.-%, based on the total weight of the encapsulated composition.
[0104] In a preferred embodiment of the present invention, the encapsulated composition is in particulate form. Further aspects of the present invention refer to powder formulations comprising such particulate encapsulated composition.
[0105] Such powder formulations may additionally contain a solid carrier. The solid carrier can be selected from the group consisting of urea, sodium chloride, sodium sulfate, sodium acetate, zeolite, sodium carbonate, sodium bicarbonate, clay, talc, calcium carbonate, magnesium sulfate, gypsum, calcium sulfate, magnesium oxide, zinc oxide, titanium dioxide, calcium chloride, potassium chloride, magnesium chloride, zinc chloride, sugars, polyethylene glycol, polyvinylpyrrolidone, citric acid or any water-soluble solid acid, aliphatic alcohol, fatty acids and mixtures thereof.
[0106] Diluting the powder contained in the carrier material makes it possible to provide a formulation that complies with dust explosion regulations, given that the risk of explosion increases as the concentration of fragrance components in the powder increases.
[0107] When a solid carrier is used, the proportion of the encapsulated composition may be 0.1 to 50 wt.-%, preferably 1 to 30 wt.-%, and more preferably 3 to 15 wt.-%, relative to the total weight of the powder formulation. The proportion of the solid carrier may be 10 to 99.9 wt.-%, preferably 30 to 97 wt.-%, and more preferably 50 to 95 wt.-%, relative to the total weight of the powder formulation. Under these conditions, the powder can be kept below the critical explosion value in terms of explosion class and minimum ignition energy value.
[0108] As an alternative to or in addition to solid carriers, powder formulations according to the present invention may also include a fluidizing agent. The fluidizing agent is selected from the group consisting of silicon dioxide, sodium salts, calcium salts, and zeolites. The fluidizing agent limits the risk of powder aggregation and clogging and facilitates the transfer of encapsulated compositions from one container to another.
[0109] A further aspect of the present invention relates to a process for preparing encapsulated compositions, particularly the compositions described herein. The process includes the following steps: a) Preparing emulsions or suspensions of fragrance compositions in solutions of matrix materials in water; b) To obtain an encapsulated composition in which the fragrance composition is confined within a water-soluble matrix, the emulsion or suspension is subjected to drying (particularly by spray drying or adsorption onto an absorbent).
[0110] The fragrance composition preferably comprises, and more preferably consists of, at least 1, preferably at least 2, more preferably at least 4, even more preferably at least 8, and even more preferably at least 16 biodegradable components, where the biodegradable components are present at a total concentration of at least 75 wt.-%, preferably at least 80 wt.-%, more preferably at least 85 wt.-%, even more preferably at least 90 wt.-%, and even more preferably at least 95 wt.-%, relative to the total weight of the fragrance composition.
[0111] Further aspects of the present invention relate to encapsulated compositions that can be obtained by the process described herein. The present invention also relates to consumer products, preferably fabric care products, home care products, or personal care products, comprising the encapsulated compositions or powder formulations described herein.
[0112] Biodegradation is particularly important for consumer products in the aforementioned categories, because during and after their intended use, the components of these products enter the environment through household wastewater. Biodegradation is the primary process of removal in wastewater treatment plants, environmental water, and soil.
[0113] The encapsulated compositions of the present invention may be used to fragrance consumer products that are anhydrous or have a water activity lower than 0.25, preferably lower than 0.1. These products include laundry care powder detergents and solid single-use detergents such as tablets, personal care cleansing compositions such as laundry care conditioner sheets, fabric refreshers, fragrance boosters, and soaps, personal care conditioning compositions such as anhydrous deodorant compositions and antiperspirant compositions, home care compositions such as powdered hard surface cleaners, and heavy-duty detergents such as dishwashing tablets.
[0114] Consumer products may contain the compositions described herein at a level of preferably 0.005 to 5 wt.-%, more preferably 0.01 to 1 wt.-%, and even more preferably 0.02 to 0.5 wt.-% of the consumer product.
[0115] A specific aspect of the present invention relates to a solid fragrance booster composition comprising an encapsulated composition or powder formulation as described herein, and a solid vehicle.
[0116] Solid fragrance boosters are used in laundry applications to provide an enhanced fragrance to laundry. They are typically applied during a wash cycle in addition to a general liquid or solid detergent or fabric softener. Solid fragrance booster compositions according to the present invention are particularly attractive, especially in terms of consumer appeal, due to their reduced environmental impact. The encapsulated compositions or powder formulations described herein have proven to be highly suitable for the manufacture of solid fragrance boosters, as they enable the provision of fragrance compositions that are in a dry form and have a very low moisture content, optionally, if required, even encapsulated in core-shell microcapsules.
[0117] The solid fragrance booster composition may be in the form of a plurality of pastilles. Each pastille may have a mass of 0.01g to 15.0g, preferably 0.01g to 5.0g, and more preferably 0.015g to 2.0g. Furthermore, each pastille may have a maximum dimension of less than 50mm, preferably less than 20mm, and more preferably less than 8mm. Furthermore, each pastille may have a shape selected from the group consisting of spherical, hemispherical, compressed hemispherical, lentil-shaped, and rectangular.
[0118] The solid fragrance booster composition may additionally include an unencapsulated fragrance composition. The unencapsulated fragrance composition may contain, preferably, at least one, preferably at least two, more preferably at least four, even more preferably at least eight, and even more preferably at least sixteen biodegradable components (one or more). The biodegradable components (one or more) may be present at a total concentration of at least 75 wt.-%, preferably at least 80 wt.-%, more preferably at least 85 wt.-%, even more preferably at least 90 wt.-%, and even more preferably at least 95 wt.-% based on the total weight of the fragrance composition. The biodegradable components (one or more) may be selected from the group identified above herein. The unencapsulated fragrance composition may be identical or different from the fragrance composition used in the encapsulated composition or powder formulation as described above herein.
[0119] Additionally or alternatively, the solid fragrance booster composition may include core-shell microcapsules comprising a core and a shell surrounding the core, which do not form part of the encapsulated composition or powder formulation as described herein.
[0120] The solid fragrance booster composition may additionally contain crystallization additives, preferably selected from the group consisting of polyols, starch derivatives, and organic acids. In particular, the crystallization additives are selected from the group consisting of citric acid, tartaric acid, sorbitol, sucralose, sucrose, maltitol, and fructose. The preferred crystallization additive is citric acid. Citric acid is a cost-effective, bio-based, and biodegradable compound that can influence the kinetics of crystallization of the solid vehicle and, consequently, the solidification of the fragrance booster composition.
[0121] Furthermore, the solid fragrance booster composition may additionally contain dyes selected from, in particular, carotenoids (E160), xanthins (E161), saffron (E164), chlorophylls (E140), copper complexes of chlorophylls and / or chlorophyllins (E141), anthocyanins (E163), carmine (E120), curcumin (E100) and their derivatives, or visual modifiers, in particular inorganic and organic pigments such as mica powder or titanium dioxide.
[0122] In another preferred embodiment, the solid fragrance booster composition further comprises fillers selected from the group consisting of, in particular, silica, sodium carbonate, sodium bicarbonate, soluble starch, pregelatinized starch, magnesium aluminum silicate, bentonite, microcrystalline cellulose, sodium carboxymethylcellulose, polyvinylpyrrolidone, guar gum, sodium starch glycolate, alginic acid, alginate, ion exchange resin, modified corn starch, sodium dodecyl sulfate, and combinations thereof.
[0123] Preferably, in the solid fragrance booster composition as described herein, the solid vehicle has a melting temperature of 40°C to 160°C, more preferably 60°C to 140°C, and even more preferably 80°C to 120°C, where the solid vehicle preferably crystallizes below its melting temperature. Regardless of its melting temperature, the solid vehicle may contain, and preferably consists of, a polyol or polyether, preferably a sugar alcohol or polyethylene glycol, in particular a sugar alcohol selected from the group consisting of erythritol, treitol, arabitol, xylitol, ribitol, mannitol, galactitol, fusitol, iditol and inositol, and more preferably xylitol. The polyethylene glycol may have a molecular weight of 2,000 to 12,000 g / mol, preferably 5,000 to 10,000 g / mol.
[0124] The proportion of solid vehicle can be 50 wt.-% to 95 wt.-% of the total weight of the solid fragrance booster composition, preferably 60 wt.-% to 90 wt.-% and more preferably 70 wt.-% to 85 wt.-%. If a crystallization additive is used, its proportion may be 0.1 wt.-% to 5.0 wt.-%, preferably 0.2 wt.-% to 4.0 wt.-%, and more preferably 0.5 wt.-% to 3.0 wt.-%, relative to the total weight of the solid fragrance booster composition.
[0125] In this specification, the proportion of the encapsulated composition or powder formulation as described above may be 1 wt.-% to 40 wt.-%, preferably 5 wt.-% to 30 wt.-%, and more preferably 10 wt.-% to 20 wt.-%, based on the total weight of the solid fragrance booster composition. When an unencapsulated fragrance composition is used, its proportion can be 1 wt.-% to 40 wt.-%, preferably 5 wt.-% to 30 wt.-%, and more preferably 10 wt.-% to 20 wt.-%, relative to the total weight of the solid fragrance booster composition.
[0126] When microcapsules are used that do not form part of the encapsulated composition or powder formulation as described above, their proportion may be 1.0 wt.-% to 30 wt.-%, preferably 2.0 wt.-% to 20 wt.-%, and more preferably 5.0 wt.-% to 15 wt.-%, based on the total weight of the solid fragrance booster composition.
[0127] If dyes or visual modifiers are used, their proportion may be 0.1 wt.-% to 5.0 wt.-%, preferably 0.2 wt.-% to 4.0 wt.-%, and more preferably 0.5 wt.-% to 2.0 wt.-%, relative to the total weight of the solid fragrance booster composition. If a filler is used, its proportion may be 1 wt.-% to 40 wt.-%, preferably 5 wt.-% to 30 wt.-%, and more preferably 10 wt.-% to 20 wt.-%, relative to the total weight of the solid fragrance booster composition.
[0128] A further aspect of the present invention relates to the use of the encapsulated compositions described herein for obtaining consumer products. This disclosure also relates to the use of encapsulated compositions as described herein to enhance the performance of fragrance compositions in consumer products, or to methods for enhancing the performance of fragrance compositions in consumer products by adding encapsulated compositions according to the present invention.
[0129] The following are preferred methods for implementing OECD Method 301F. principle: As the sole nominal source of organic carbon, a weighed inoculated inorganic medium containing a known concentration of the test substance is stirred in a sealed flask at a constant temperature. Evaporated carbon dioxide is absorbed by a sodium hydroxide pellet. Oxygen consumption is determined by measuring the pressure drop in the respirometer flask. The biological oxygen demand (BOD), i.e., the amount of oxygen taken in by the microbial population during the biodegradation of the test chemical (corrected for uptake by a parallel blank inoculation), is expressed as a percentage of ThOD (theoretical oxygen demand, calculated from elemental composition assuming carbon is oxidized to carbon dioxide, hydrogen to water, and nitrogen to ammonium, nitrite, or nitrate).
[0130] Device: The respirometer used was manufactured by Oxitop Control System, Wissenschaftlich-Technische Werkstaetten (WTW), Weilheim, Germany. water: The water used is ultrapure water with a total organic carbon content of less than 5 ppb, produced using the Millipore Direct-Q 3 UV purification system.
[0131] Stock solution of mineral components: Solution A: KH2PO 48.5g K2HPO4 21.75g Na2HPO4·2H2O 33.4g NH4Cl 0.5g It was dissolved in water to make 1 liter. Solution B: CaCl2 27.5g It was dissolved in water to make 1 liter. Solution C: MgSO4·7H2O 22.5g It was dissolved in water to make 1 liter. Solution D: FeCl3·6H2O 0.25g 1 drop of HCl Conc. It was dissolved in water to make 1 liter.
[0132] Inorganic medium: The inorganic medium is prepared by mixing 50 ml of solution A with 2 liters of deionized water, adding 5 ml each of solutions B, C, and D, and then bringing the total volume to 5 liters with deionized water. The pH is measured and adjusted to 7.4 ± 0.2 with phosphoric acid or potassium hydroxide if necessary.
[0133] Inoculation: It primarily uses fresh activated sludge from biological wastewater treatment facilities (Bois-de-Bay, Satigny, Switzerland) that treat domestic wastewater. The sludge is collected in the morning, washed three times in an inorganic medium (by centrifuging 1000g for 10 minutes, discarding the supernatant, and resuspending it in an inorganic medium), and stored under aerobic conditions until use on the same day.
[0134] Determination of the dry weight of a suspended solid: The dry weight of the suspended solid is determined by taking two 50 ml samples of homogenized sludge, evaporating the water in a steam bath, drying them in an oven at 105-110°C for 2 hours, and measuring the weight of the residue. Reference substance: Sodium benzoate (Fluka, Buchs, Switzerland, Art. No. 71300), purity: minimum 99.0%.
[0135] Flask preparation: The test substance sample (equivalent to 30.0 mg / l in 255 ml of test medium) is weighed into a small aluminum boat and added directly to the Oxitop test flask. The reference substance sample (12.75 mg, equivalent to 50.0 mg / l in 255 ml of test medium) is weighed into a small aluminum boat and added directly to the Oxitop test flask.
[0136] Fill the flask with 250 ml of inorganic medium. Add a sample of the test or reference substance. Then add 5.00 ml of suspended sludge diluted to a concentration of 1.53 g / l dry material. Unless the test substance has acidic or alkaline characteristics, the pH of each flask is not measured and is assumed to be the same as that of the inorganic medium, so as not to remove any undissolved test substance suspended in the test solution by immersing the glass electrode in the test medium. It has been shown that even a neutral test substance, sodium benzoate, does not affect the pH of the medium by more than 0.1 pH units. Place two pellets of sodium hydroxide in the pipe on top of the bottle and tightly close the flask with the measuring head. Allow the flask to equilibrate to the test temperature. Start the measurement by programming the measuring unit of the Oxitop test flask and place the test flask in a temperature-controlled cabinet of the Oxitop system. After temperature equilibrium, the instrument's controller starts data acquisition (zero hour of the experiment).
[0137] Test temperature: The test temperature is 21.5 ± 0.5°C. Conducting the test: Record the oxygen consumption of each flask daily and verify the correct temperature and stirring. At the end of the test period (usually 28 days), remeasure the pH of each flask.
[0138] The biodegradation of each data point is calculated as follows: D = (CB) / ThOD · 100% D: Biodegradation of the sample C: O2 uptake of samples and sludge B: O2 uptake in sludge (inoculation blank) ThOD: Theoretical Oxygen Demand
[0139] The passing level for "easily biodegradable" is reaching 60% of the theoretical oxygen demand (ThOD). This passing value must be reached within a 10-day window during the 28-day testing period. This 10-day window begins when the ThOD reaches 10% and must be completed by the 28th day of the testing period. The passing level for "inherent biodegradability" is also 60% of the theoretical oxygen demand (ThOD). However, this passing value can be reached after a 28-day testing period, which is usually extended to 60 days. The 10-day limit does not apply. [Examples]
[0140] Further features and specific advantages of the present invention will become apparent from the following examples. Example 1: Fragrance composition consisting of biodegradable components A fragrance composition consisting of biodegradable components can be prepared by mixing such components according to the formulations given in Table 1.
[0141] Table 1 [Table 1] JPEG2023553286000004.jpg240163JPEG2023553286000005.jpg229163JPEG2023553286000006.jpg75163
[0142] Example 2: Decomposition test of fragrance composition Fragrance compositions according to Table 1 can be subjected to the biodegradation tests described herein as described above. Since all components used in these fragrance compositions are biodegradable, it will be understood that these fragrance compositions are particularly beneficial from a biodegradation standpoint.
[0143] Example 3: Preparation of encapsulated compositions An encapsulated composition according to the present invention can be prepared as follows: 50.0 g of tap water is weighed into a stainless steel beaker. 20.0 g of sodium starch octenyl succinate E1450, 3.0 g of starch modification Hi-Cap 100, and 6.0 g of maltodextrin Glucidex IT-19 are then weighed into the same beaker. The resulting mixture is first manually stirred with a stainless steel rod, and then homogenized at 13,500 rpm using an IKA T25 Ultra-Turrax Homogenizer to obtain a homogeneous solution. To this mixture, 20.0 g of perfume oil (Table 1) is added. An emulsion is then produced by high-shear mixing at 22,000–24,000 rpm for 20–30 minutes using the same homogenizer. Droplet size is controlled by dynamic light scattering to be between 0.5 μm and 2 μm.
[0144] The emulsion is subjected to spray drying using a LabPlant SD-06 Spray Dryer. The spray drying process parameters are as follows: - Inlet temperature: 190℃ - Outlet temperature: 90℃ - Peristaltic pump speed: 485 mL / h - Airflow rate: 3.7 m / s The resulting spray-dried powder is mixed with silicon dioxide Aerosil 200 (1.0 g) in a sealed mixing container.
[0145] Example 4: Preparation of encapsulated compositions Another example of an encapsulated composition according to the present invention can be prepared as follows: 55.0g of tap water is weighed into a stainless steel beaker. 18.7g of sodium starch octenyl succinate E1450, 2.2g of starch modification Hi-Cap 100, 5.3g of maltodextrin Glucidex IT-19, and 0.5g of tamarind kernel powder are then weighed into the same beaker. The resulting mixture is first manually stirred with a stainless steel rod, and then homogenized at 13,500 rpm using an IKA T25 Ultra-Turrax Homogenizer to obtain a homogeneous solution. To this mixture, 17.8g of fragrant oil (Table 1) is added. An emulsion is then produced by high-shear mixing at 22,000-24,000 rpm for 20-30 minutes using the same homogenizer. The droplet size is controlled by dynamic light scattering to be between 0.5 μm and 2 μm.
[0146] The emulsion is subjected to spray drying using a LabPlant SD-06 Spray Dryer. The spray drying process parameters are as follows: - Inlet temperature: 190℃ - Outlet temperature: 90℃ - Peristaltic pump speed: 485 mL / h - Airflow rate: 3.7 m / s The resulting spray-dried powder is mixed with silicon dioxide Aerosil 200 (0.5 g) in a sealed mixing container.
[0147] Example 5: Preparation of encapsulated compositions Yet another example of an encapsulated composition according to the present invention can be prepared as follows: 45.0 g of tap water is weighed into a stainless steel beaker. 21.9 g of sodium starch octenylsuccinate E1450, 5.5 g of mannitol 60, and 0.5 g of tamarind kernel powder are then weighed into the same beaker. The resulting mixture is first manually stirred with a stainless steel rod, and then homogenized at 13,500 rpm using an IKA T25 Ultra-Turrax Homogenizer to obtain a homogeneous solution. 27.3 g of perfumed oil (Table 1) is added to the resulting mixture. An emulsion is then produced by high-shear mixing at 22,000–24,000 rpm for 20–30 minutes using the same homogenizer. Droplet size is controlled by dynamic light scattering to be between 0.5 μm and 2 μm.
[0148] The emulsion is subjected to spray drying using a LabPlant SD-06 Spray Dryer. The spray drying process parameters are as follows: - Inlet temperature: 190℃ - Outlet temperature: 90℃ - Peristaltic pump speed: 485 mL / h - Airflow rate: 3.7 m / s The resulting spray-dried powder is mixed with silicon dioxide Aerosil 200 (0.5 g) in a sealed mixing container.
[0149] Example 6: Preparation of encapsulated compositions Further examples of encapsulated compositions according to the present invention can be prepared as follows: 55.0 g of tap water is weighed into a stainless steel beaker. 12.3 g of sodium starch octenyl succinate E1450 and 3.1 g of mannitol 60 are then weighed into the same beaker. The resulting mixture is first manually stirred with a stainless steel rod, and then homogenized at 13,500 rpm using an IKA T25 Ultra-Turrax Homogenizer to obtain a homogeneous solution. To this mixture, 15.3 g of perfumed oil (Table 1) is added. An emulsion is then produced by high-shear mixing at 22,000–24,000 rpm for 20–30 minutes using the same homogenizer. Droplet size is controlled by dynamic light scattering to be between 0.5 μm and 2 μm.
[0150] Add a slurry of core-shell microcapsules (e.g., containing 7-12; 14.0 g; 5.1 g of encapsulated fragrance) to the emulsion and shake at 300 rpm for 10 minutes. The resulting mixture is subjected to spray drying using a LabPlant SD-06 Spray Dryer. The spray drying process parameters are as follows: - Inlet temperature: 180℃ - Outlet temperature: 80℃ - Peristaltic pump speed: 485 mL / h - Airflow rate: 3.7 m / s The resulting spray-dried powder is mixed with silicon dioxide Aerosil 200 (0.3 g) and sodium sulfate (90 g) in a sealed mixing container.
[0151] Example 7: Preparation of melamine-formaldehyde microcapsules Melamine-formaldehyde core-shell microcapsules for use in the present invention can be prepared by following the procedure below with the fragrance composition described herein (Table 1): - WO 2008 / 098387 Example 1.3 of A1 - Example 1 of WO 2016 / 207180 A1 - Example 1 of WO 2017 / 001672 A1
[0152] Example 8: Preparation of polyurea microcapsules Polyurea core-shell microcapsules for use in the present invention can be prepared by following the procedure below with the fragrance compositions described herein (Table 1): - Example 1 of WO 2019 / 174978 A1
[0153] Example 9: Preparation of Cellulose Microcapsules Core-shell microcapsules for use in the present invention can be prepared by performing the following steps: a) Prepare by mixing 0.66 g of bipodial aminosilane (bis(3-triethoxysilylpropyl)amine), 0.48 g of Takenate D-110N (ex Mitsui), and 38.5 g of the fragrance as specified above (Table 1); b) Emulsify the core composition obtained in step a) in a mixture of 66.2 g of 1.35 g of high-methoxylated grade pectin (type APA 104, ex Roeper) in water using a cross-beam stirrer with a pitched beam, in a 300 ml reactor and at a stirring speed of 800 rpm for 10 minutes at a temperature of 25 ± 2°C; c) Adjust the pH of the continuous phase of the emulsion to 6.5 ± 0.5 with a 10% sodium hydroxide solution in water, and maintain the system at a temperature of 25 ± 2°C for 1 hour while maintaining the stirring in step b); d) Gradually raise the temperature to 85°C over 2.5 hours, and maintain the temperature at 85°C for 1 hour while continuing the stirring in steps b) and c) to complete the formation of the core-shell capsule; e) Add 1.8 g of 2-hydroxyethylcellulose and continue stirring at 85°C for 30 minutes; f) Add 0.8 g of a 30% diluted citric acid solution to water and continue stirring at 85°C for 1 hour; g) Cool the core-shell capsule slurry obtained in step f) to room temperature.
[0154] Example 10: Preparation of gelatin coacervate microcapsules Gelatin corecervate core-shell microcapsules for use in the present invention can be prepared by following the procedure below with the fragrance compositions described herein (Table 1): - Example 1 of WO 1996 / 020612 A1 - Example 2 of WO 2001 / 03825 A1 - WO 2015 / 150370 A1 Example 1-3
[0155] Example 11: Preparation of gelatin coacervate microcapsules Core-shell microcapsules for use in the present invention can be prepared by performing the following steps: a) To provide a core composition by dissolving 70 g of a trifunctional aromatic aliphatic isocyanate (Takenate N100-D, ex Mitsui Inc., 75 wt.-% activity content) in 165 g of the fragrance as described above (Table 1); b) Provide an aqueous phase by mixing 17 g of type B gelatin with 150 g of deionized water; c) Heat the aqueous phase to 35°C under stirring to dissolve the gelatin; d) Emulsify the core composition in the aqueous phase obtained in step c) at a stirring speed of 1000 rpm to obtain an emulsion of core composition droplets having a volume average diameter Dv(50) of 50 μm dispersed in water; e) Heat the emulsion obtained in step d) to a temperature of 90°C and maintain the emulsion at this temperature for 10 minutes; f) Cool the slurry obtained in step e) to a temperature of 31°C to induce simple coacervation of cross-linked gelatin at the core-water interface, thereby forming a slurry of core-shell microcapsules; g) Add 80 g of 2 wt.-% aqueous carboxymethylcellulose solution to deionized water, and then add 534 g of deionized water to the slurry formed in step f) while maintaining a stirring speed of 1000 rpm; h) Adjust the pH of the slurry to 5.3 with a 10 wt.-% citric acid solution in water; reduce the stirring speed to 600 rpm and form cross-linked gelatin / polysaccharide coacervates on the surface of the microcapsules obtained in step f); i) Cool the slurry obtained in step h) to a temperature of 10-15°C over 1 hour; j) Add 26 g of glutaraldehyde to the slurry while stirring and maintaining the slurry at 15°C for 1 minute. Allow the slurry to warm to room temperature over 1 hour to obtain a slurry of microcapsules. k) Complete the mixture to 1000g using deionized water.
[0156] Example 12: Preparation of polyacrylate-based microcapsules Core-shell microcapsules for use in the present invention, based on polyacrylate, can be prepared by following the procedure below with the fragrance compositions described herein (Table 1): - Example 1 of WO 2013 / 111912 A1 - WO 2014 / 032920 Example 1 of A1
[0157] Example 13: Preparation of a solid fragrance booster composition A solid fragrance booster composition can be prepared by following these steps: a) In a 150 ml beaker, combine xylitol powder (77 g) with citric acid solution in water (55% in water; 3 g); b) Raise the temperature of the resulting mixture to 120°C and maintain it until the mixture is completely melted; c) Stir the high-temperature molten material at 50 RPM for 5 minutes. Then reduce the temperature to 95°C; d) Add the slurry of core-shell microcapsules (e.g., 7-12; 9 g; containing 3.6 g of encapsulated fragrance) and maintain stirring until the capsules are uniformly dispersed; e) Increase the mixing speed to 500 RPM and disperse the encapsulated fragrance composition (11 g) according to any one of Examples 3-5 in the hot molten material; f) The mixture is pumped and distributed onto the silicone substrate as hemispherical droplets; g) Crystallize hemispherical droplets at room temperature; h) Obtain a solid fragrance booster pastil containing both encapsulated fragrance and free oil.
[0158] Example 14: Preparation of a solid fragrance booster composition A solid fragrance booster composition can be prepared by following these steps: a) In a 150 ml beaker, combine xylitol powder (81 g) with citric acid solution in water (55% in water; 3 g); b) Raise the temperature of the resulting mixture to 120°C and maintain it until the mixture is completely melted; c) Stir the high-temperature molten material at 50 RPM for 5 minutes. Then reduce the temperature to 95°C; d) Increase the mixing speed to 500 RPM and disperse the encapsulated fragrance composition (16 g) according to Example 6 in the hot molten material; e) Pump the mixture and distribute it onto the silicone substrate as hemispherical droplets; f) Crystallize a hemispherical droplet at room temperature; g) Obtain a solid fragrance booster pastil containing both encapsulated fragrance and free oil.
[0159] Example 15: Preparation of a solid fragrance booster composition A solid fragrance booster composition can be prepared by following these steps: a) In a 150 ml beaker, combine xylitol powder (79 g) with a citric acid solution in water (55% in water; 3 g); b) Raise the temperature of the resulting mixture to 120 °C and maintain until the mixture is completely melted; c) Stir the hot melt at 50 RPM for 5 minutes. Then lower the temperature to 95 °C; d) Add a slurry of spray - dried core - shell microcapsules (Examples 7 - 12; 7 g; containing 3.5 g of encapsulated fragrance) and maintain stirring until the capsules are uniformly dispersed; e) Increase the mixing to up to 500 RPM and disperse an encapsulated fragrance composition (11 g) according to any one of Examples 3 - 5 into the hot melt; f) Pump the mixture and dispense as hemispherical droplets onto a silicone substrate; g) Crystallize the hemispherical droplets at room temperature; h) Obtain a solid fragrance booster pastille containing both encapsulated fragrance and free oil.
Claims
1. An encapsulated composition comprising a perfume composition entrapped in a water-soluble matrix, wherein the perfume composition comprises, preferably consists of, at least one, preferably at least two, more preferably at least four, even more preferably at least eight, and even more preferably at least sixteen biodegradable ingredient(s), wherein the biodegradable ingredient(s) are present in a combined concentration of at least 75 wt.-%, preferably at least 80 wt.-%, more preferably at least 85 wt.-%, even more preferably at least 90 wt.-%, and even more preferably at least 95 wt.-%, based on the total weight of the perfume composition.
2. The biodegradable component(s) may be 1-phenylethanone; 2,6,10-trimethylundec-9-enal; 2-(tert-butyl)cyclohexyl acetate; hexan-1-ol; decanal; 2-methyldecanal; undec-10-enal; undecanal; dodecanal; 2-methylundecanal; hexan-1-al; octanal; 3,5,5-trimethylhexanal; nonanal; (E)-undec-9-enal; prop-2-enyl 2-(3-methylbutoxy)acetate; prop-2-enyl hexanoate; prop-2-enyl 3-cyclohexylpropanoate; prop-2-enyl heptanoate; 3,8,8,11a-tetramethyldodecahydro-1H-3,5a-epoxynaphtho[2,1-c]oxepin; (Z)- Oxacycloheptadec-10-en-2-one; (3aR,5aS,9aS,9bR)-3a,6,6,9a-tetramethyl-2,4,5,5a,7,8,9,9b-octahydro-1H-benzo[e][1]benzofuran; Pentyl butanoate; (Z)-2-benzylideneheptanal; Pentyl 2-hydroxybenzoate; (E)-1-methoxy-4-(prop-1-en-1-yl)benzene; 4-Methoxybenzyl acetate; 1-(3,3-dimethylcyclohexyl)ethyl formate; 4-Methoxybenzaldehyde; (E)-Methyl 2-((7-hydroxy-3,7-dimethyloctylidene)amino)benzoate; Benzaldehyde; Benzyl acetate; 4-Phenylbutan-2-one; Phenylmethanol; Benzyl benzoate; Benzyl 3-phenylprop-2-enoate; Benzyl 2-hydroxybenzoate; Octahydro-2H-chromen-2-one; (1S,2S, 4S)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-ol; (2S,4S)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl acetate; 3-(4-(tert-butyl)phenyl)propanal; butyl acetate; 4-(tert-butyl)cyclohexyl acetate; (1S,4S)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-one; (5R)-2-methyl-5-prop-1-en-2-ylcyclohex-2-en-1-one; (1R,6S,8aS)-6-Methoxy-1,4,4,6-tetramethyloctahydro-1H-5,8a-methanoazulene; (E)-1-(2,6,6-trimethylcyclohex-2-en-1-yl)hepta-1,6-dien-3-one; (E)-3-phenylprop-2-en-1-ol; (2E)-3-phenylprop-2-enal; (E)-3-phenylprop-2-en-1-yl acetate; (Z)-hex-3-en-1-ol; (Z)-3-methyl-2-(pent-2-en-1-yl)cyclopent-2-enone; (E)-3,7-dimethylocta-2,6-dienal; 3,7-dimethyloct-6-enal; 3,7-dimethyloct-6-en-1-ol; 3,7-dimethyloct-6-en-1-yl acetate; 3,7-dimethyloct-6-en-1-yl formate; 3,7-dimethyloct-6-enenitrile; dodecanenitrile; 4-cyclohexyl-2-methylbutan-2-ol; 2-hydroxy-3-methylcyclopent-2-enone; (Z)-3-methylcyclotetradec-5-enone; 2H-chromen-2-one; 1-methoxy-4-methylbenzene; 4-isopropylbenzonitrile; 3-(4-isopropylphenyl)-2-methylpropanal; (E)-1-(2,6,6-trimethylcyclohex-1,3-dien-1-yl)but-2-en-1-one; (E)-1-(2,6,6-trimethylcyclohex-2-en-1-yl)but-2-en-1-one; 5-Hexyloxolan-2-one; (E)-Deca-4-enal; 1-Methoxy-4-propylbenzene; 2,6-Dimethyloct-7-en-2-ol; 2-Methyl-1-phenylpropan-2-yl acetate; 2-Methyl-1-phenylpropan-2-yl butanoate; 2,6-dimethylheptan-2-ol; Oxydibenzene; (E)-Dodec-2-enal; (E)-3-Methyl-5-(2,2,3-trimethylcyclopent-3-en-1-yl)pent-4-en-2-ol; Ethyl cyclohexyl carboxylate; Ethyl acetate; Ethyl 3-oxobutanoate; Ethyl 3-phenylprop-2-enoate; Ethylhexa noate; (E)-3,7-dimethylnona-1,6-dien-3-ol; 2-ethyl-3-hydroxy-4H-pyran-4-one; ethyl 2-methylbutanoate; ethyl heptanoate; 3-ethoxy-4-hydroxybenzaldehyde; 1,4-dioxacycloheptadecane-5,17-dione; (1s,4s)-1,3,3-trimethyl-2-oxabicyclo[2.2.2]octane; 4-allyl-2-methoxyphenol; methyl 2,4-dihydroxy-3,6-dimethylbenzoate; (1S,2R,4R)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-ol; 3-(4-methoxyphenyl)-2-methylpropanal; 3-(3-isopropylphenyl)butanal; tetrahydro-4-methyl-2-(2-methylpropyl)-2H-pyran-4-ol; 2-(sec-butyl)cyclohexanone; 2-methyldecanenitrile; 1-(5,5-di Methyl 3-oxo-2-pentylcyclohex-1-en-1-yl)pent-4-en-1-one; (E)-3,7-dimethylocta-2,6-dien-1-ol; (E)-3,7-dimethylocta-2,6-dien-1-yl acetate; (E)-6,10-dimethylundeca-5,9-dien-2-one; (E)-oxacyclohexadec-12-en-2-one; Methyl 3-oxo-2-pentylcyclo Pentane acetate; Benzo[d][1,3]dioxole-5-carbaldehyde; (E)-hex-2-enal; (Z)-hex-3-en-1-ol; (Z)-hex-3-en-1-yl acetate; (Z)-hex-3-en-1-yl 2-methylpropanoate; (Z)-hex-3-en-1-yl 2-hydroxybenzoate; hexyl acetate; (E)-2-benzoyl 7-hydroxy-3,7-dimethyloctanal; 1H-indole; (E)-4-(2,6,6-trimethylcyclohex-1-en-1-yl)but-3-en-2-one; (E)-4-(2,6,6-trimethylcyclohex-2-en-1-yl)but-3-en-2-one; 3-Methylbutyl acetate; (E)-2-Methoxy-4-(prop-1-en-1-yl)phenol; 2-Isopropyl-5-methylcyclohexanone; Isopropyl 2-methylbutanoate; (E)-3-Methyl-4-(2,6,6-trimethylcyclohex-2-en-1-yl)but-3-en-2-one; (Z)-3-Methyl-2-(pent-2-en-1-yl)cyclopent-2-enone; 3-Butyl-5-methyltetrahydro-2H-pyran-4-yl acetate; 3-Pentyltetrahydroacetate 1-Methyl-4-prop-1-en-2-yl-cyclohexene; 2-(5-methyl-5-vinyltetrahydrofuran-2-yl)propan-2-ol; 3,7-dimethylocta-1,6-dien-3-ol; 3,7-dimethylocta-1,6-dien-3-yl acetate; (4E)-9-hydroxy-5,9-dimethyl-4-decanal; 3-Hydroxy-2-methyl-4H-pyran-4-one; Ethyl 2-methylpentanoate; (4-isopropylcyclohexyl)methanol; 3-Methyl-5-phenylpentan-1-ol; 2,6-Dimethylhept-5-enal; 2-Isopropyl-5-methylcyclohexanol; 2-Isopropyl-5-methylcyclohexanone; Methyl 2-aminobenzoate; Methyl benzoate; Methyl 3-phenylprop-2-enoate; 2-Ethoxy-4-(meth) (xymethyl)phenol; methyl 2-hexyl-3-oxocyclopentane-1-carboxylate; 6-methylhept-5-en-2-one; 8-methyl-1-oxaspiro[4.5]decan-2-one; methyl non-2-ynoate; methyl 2-hydroxybenzoate; (Z)-3-methylcyclopentadec-5-enone; 4-(4-methylpent-3-en-1-yl)cyclohex-3-enecarbaldehyde; 7-methyl-3-methyleneocta-1,6-diene; 2-Methylundecanoic acid; 2-(2-(4-methylcyclohex-3-en-1-yl)propyl)cyclopentanone; (E)-methylnon-2-enoate; (2Z)-3,7-dimethylocta-2,6-dien-1-ol; (E)-3,7,11-trimethyldodeca-1,6,10-trien-3-ol; 2-ethoxynaphthalene; (Z)-3,7-dimethylocta-2,6-dien-1-yl acetate; (E)-13-methyloxacyclopentadec-10-en-2-one; (2E,6Z)-nona-2,6-dienal; (2Z,6E)-2,6-nonadiene-1-ol; 5-Pentyloxolan-2-one; (Z)-Nona-6-enal; (Z)-Nona-6-en-1-ol; 2-(6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)ethyl acetate; 3-(4-(2-methylpropyl)-2-methylphenyl)propanal; Octan-2-one; 1-(2-naphthalenyl)-ethanone; (2-methoxyethyl)benzene; 5-heptyldihydrofuran-2(3H)-one; 3,7-dimethyloctan-1-ol; 2-Cyclohexylhepta-1,6-dien-3-one; 2-(Phenoxy)ethyl 2-methylpropanoate; 2-Phenyl-ethanal; 2-Phenylethyl acetate; 2-Phenylethanol; 2-Phenylethyl 2-methylpropanoate; 2-Phenylethyl 2-phenylacetate; 3-Phenylpropan-1-ol; 6,6-Dimethyl-2-methylenebicyclo[3.1.1]heptane; 3-(6,6-Dimethylbicyclo[3.1.1]hept-2-ene (2E,5E)-5,6,7-trimethylocta-2,5-dien-4-one; 1-methyl-4-(4-methylpent-3-en-1-yl)cyclohex-3-enecarbaldehyde; 3-methylbut-2-en-1-yl acetate; 4-(4-hydroxyphenyl)butan-2-one; 4-methyl-2-(2-methylprop-1-en-1-yl)tetrahydro-2H-pyran; 4-methyl-2-phenyl-3,6-dihydro-2H-pyran; 3-Methyl-5-(2,2,3-trimethylcyclopent-3-en-1-yl)pentan-2-ol; Ethyl (Z)-2-acetyl-4-methyltridec-2-enoate; 4-(dodecylthio)-4-methylpentan-2-one; Cyclopentadecanone, hexadecanolide; 1-Phenylethyl acetate; (E)-6-Ethyl-3-methyloct-6-en-1-ol; (E)-2-((3,5-dimethylhex-3-en-2-yl)oxy)-2-methylpropyl cyclopropanecarboxylate; 1-Methyl-4-propane 2-(4-methylcyclohex-3-enyl)propan-2-ol; 2-(4-methylcyclohex-3-en-1-yl)propan-2-ol; 1-methyl-4-(propan-2-ylidene)cyclohex-1-ene; 2-(4-methyl-1-cyclohex-3-enyl)propan-2-yl acetate; 3,7-dimethyloctan-3-ol; oxacyclohexadecan-2-one; 2-isopropyl-5-methylphenol; 1-(cyclopropylmethyl)-4-methoxy Benzene; (E)-tridec-2-enenitrile; 3-phenylbutanal; 3-(benzo[d][1,3]dioxol-5-yl)-2-methylpropanal; undecan-2-one; (3E,5Z)-Undeca-1,3,5-triene; (E)-4-methyldec-3-en-5-ol; 4-hydroxy-3-methoxybenzaldehyde; (Z)-Cyclohexadec-5-enone; (2E,6Z)-Nona-2,6-dienenitrile; and 2-methoxynaphthalene.
2. The encapsulated composition of claim 1, selected from the group consisting of:
3. 3. The encapsulated composition of claim 2, wherein each of the biodegradable component(s) is present at a concentration equal to or less than the maximum concentration of: 1-Phenylethanone: 0.5 wt.-% 2,6,10-trimethylundec-9-enal: 1 wt. -% 2-(tert-butyl)cyclohexyl acetate: 50 wt. -% Hexane-1-ol: 10 wt.-% Decal: 10 wt.-% 2-Methyldecanal: 0.5 wt.-% Undec-10-enal: 2 wt. -% Undecanal: 5 wt.-% Dodecanal: 10 wt.-% 2-Methylundecanal: 50 wt.-% Hexanal: 5 wt.-% Octanal: 5 wt.-% 3,5,5-trimethylhexanal: 0.5 wt.-% Nonanal: 5 wt.-% (E)-Undec-9-enal: 5 wt. -% Prop-2-enyl 2-(3-methylbutoxy)acetate: 5 wt. -% Prop-2-enyl hexanoate: 5 wt. -% Prop-2-enyl 3-cyclohexylpropanoate: 10 wt.-% Prop-2-enylheptanoate: 10 wt.-% 3,8,8,11a-tetramethyldodecahydro-1H-3,5a-epoxynaphtho[2,1-c]oxepin: 2 wt. -% (Z)-Oxacycloheptadec-10-en-2-one: 2 wt. -% (3aR,5aS,9aS,9bR)-3a,6,6,9a-tetramethyl-2,4,5,5a,7,8,9,9b-octahydro-1H-benzo[e][1]benzofuran: 2 wt. -% Pentyl butanoate: 2 wt.-% (Z)-2-benzylideneheptanal: 5 wt. -% Pentyl 2-hydroxybenzoate: 50 wt.-% (E)-1-Methoxy-4-(prop-1-en-1-yl)benzene: 2 wt. -% 4-Methoxybenzyl acetate: 15 wt.-% 1-(3,3-dimethylcyclohexyl)ethyl formate: 0.5 wt. -% 4-Methoxybenzaldehyde: 5 wt. -% (E)-Methyl 2-((7-hydroxy-3,7-dimethyloctylidene)amino)benzoate: 0.2 wt. -% Benzaldehyde: 1 wt.-% Benzyl acetate: 10 wt.-% 4-phenylbutan-2-one: 10 wt. -% Phenylmethanol: 10 wt.-% Benzyl benzoate: 85 wt.-% Benzyl 3-phenylprop-2-enoate: 2 wt. -% Benzyl 2-hydroxybenzoate: 75 wt.-% Octahydro-2H-chromen-2-one: 2 wt. -% (1S,2S,4S)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-ol: 10 wt. -% (2S,4S)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl acetate: 35 wt. -% 3-(4-(tert-butyl)phenyl)propanal: 2 wt. -% Butyl acetate: 2 wt. -% 4-(tert-butyl)cyclohexyl acetate: 50 wt. -% (1S,4S)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-one: 25 wt. -% (5R)-2-methyl-5-prop-1-en-2-ylcyclohex-2-en-1-one: 25 wt. -% (1R,6S,8aS)-6-Methoxy-1,4,4,6-tetramethyloctahydro-1H-5,8a-methanoazulene: 5 wt. -% (E)-1-(2,6,6-trimethylcyclohex-2-en-1-yl)hepta-1,6-dien-3-one: 0.5 wt. -% (E)-3-phenylprop-2-en-1-ol: 10 wt. -% (2E)-3-phenylprop-2-enal: 35 wt. -% (E)-3-phenylprop-2-en-1-yl acetate: 0.5 wt. -% (Z)-Hex-3-en-1-ol: 25 wt. -% (Z)-3-methyl-2-(pent-2-en-1-yl)cyclopent-2-enone: 2 wt. -% (E)-3,7-dimethylocta-2,6-dienal: 5 wt. -% 3,7-Dimethyloct-6-enal: 1 wt. -% 3,7-Dimethyloct-6-en-1-ol: 25 wt. -% 3,7-Dimethyloct-6-en-1-yl acetate: 25 wt. -% 3,7-Dimethyloct-6-en-1-yl formate: 1 wt. -% 3,7-Dimethyloct-6-enenitrile: 10 wt. -% Dodecanenitrile: 10 wt. -% 4-Cyclohexyl-2-methylbutan-2-ol: 5 wt. -% 2-Hydroxy-3-methylcyclopent-2-enone: 5 wt. -% (Z)-3-methylcyclotetradec-5-enone: 5 wt. -% 2H-chromen-2-one: 5 wt. -% 1-Methoxy-4-methylbenzene: 1 wt. -% 4-Isopropylbenzonitrile: 0.5 wt.-% 3-(4-isopropylphenyl)-2-methylpropanal: 5 wt. -% (E)-1-(2,6,6-trimethylcyclohexa-1,3-dien-1-yl)but-2-en-1-one: 2.5 wt. -% (E)-1-(2,6,6-trimethylcyclohex-2-en-1-yl)but-2-en-1-one: 5 wt. -% 5-Hexyloxolan-2-one: 15 wt. -% (E)-Deca-4-enal: 1 wt.-% 1-Methoxy-4-propylbenzene: 2 wt.-% 2,6-Dimethyloct-7-en-2-ol: 50 wt. -% 2-Methyl-1-phenylpropan-2-yl acetate: 75 wt. -% 2-Methyl-1-phenylpropan-2-ylbutanoate: 50 wt. -% 2,6-Dimethylheptan-2-ol: 5 wt. -% Oxydibenzene: 15 wt.-% (E)-dodec-2-enal: 0.1 wt.-% (E)-3-Methyl-5-(2,2,3-trimethylcyclopent-3-en-1-yl)pent-4-en-2-ol: 5 wt. -% Ethyl cyclohexyl carboxylate: 0.5 wt.-% Ethyl acetate: 10 wt.-% Ethyl 3-oxobutanoate: 2 wt.-% Ethyl 3-phenylprop-2-enoate: 2 wt. -% Ethylhexanoate: 10 wt.-% (E)-3,7-dimethylnona-1,6-dien-3-ol: 35 wt. -% 2-Ethyl-3-hydroxy-4H-pyran-4-one: 10 wt. -% Ethyl 2-methylbutanoate: 15 wt.-% Ethyl heptanoate: 5 wt.-% 3-ethoxy-4-hydroxybenzaldehyde: 10 wt.-% 1,4-dioxacycloheptadecane-5,17-dione: 25 wt. -% (1s,4s)-1,3,3-trimethyl-2-oxabicyclo[2.2.2]octane: 25 wt. -% 4-Allyl-2-methoxyphenol: 5 wt.-% Methyl 2,4-dihydroxy-3,6-dimethylbenzoate: 2 wt. -% (1S,2R,4R)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-ol: 2 wt. -% 3-(4-methoxyphenyl)-2-methylpropanal: 2 wt. -% 3-(3-isopropylphenyl)butanal: 5 wt. -% Tetrahydro-4-methyl-2-(2-methylpropyl)-2H-pyran-4-ol: 10 wt. -% 2-(sec-butyl)cyclohexanone: 10 wt. -% 2-Methyldecanenitrile: 1 wt. -% 1-(5,5-dimethylcyclohex-1-en-1-yl)pent-4-en-1-one: 5 wt. -% (E)-3,7-dimethylocta-2,6-dien-1-ol: 25 wt. -% (E)-3,7-dimethylocta-2,6-dien-1-yl acetate: 10 wt. -% (E)-6,10-dimethylundeca-5,9-dien-2-one: 1 wt. -% (E)-Oxacyclohexadec-12-en-2-one: 15 wt. -% Methyl 3-oxo-2-pentylcyclopentaneacetate: 75 wt. -% Benzo[d][1,3]dioxole-5-carbaldehyde: 10 wt. -% (E)-Hex-2-enal: 1 wt.-% (Z)-Hex-3-en-1-ol: 15 wt. -% (Z)-hex-3-en-1-yl acetate: 15 wt. -% (Z)-hex-3-en-1-yl 2-methylpropanoate: 1 wt. -% (Z)-hex-3-en-1-yl 2-hydroxybenzoate: 15 wt. -% Hexyl acetate: 15 wt.-% (E)-2-benzylidene octanal: 25 wt. -% Hexyl 2-methylpropanoate: 5 wt.-% Hexyl 2-hydroxybenzoate: 85 wt.-% 7-Hydroxy-3,7-dimethyloctanal: 1 wt. -% 1H-indole: 0.5 wt.-% (E)-4-(2,6,6-trimethylcyclohex-1-en-1-yl)but-3-en-2-one: 25 wt. -% (E)-4-(2,6,6-trimethylcyclohex-2-en-1-yl)but-3-en-2-one: 25 wt. -% 3-Methylbutyl acetate: 5 wt. -% (E)-2-Methoxy-4-(prop-1-en-1-yl)phenol: 1 wt. -% 2-isopropyl-5-methylcyclohexanone: 1 wt. -% Isopropyl 2-methylbutanoate: 5 wt.-% (E)-3-methyl-4-(2,6,6-trimethylcyclohex-2-en-1-yl)but-3-en-2-one: 50 wt. -% (Z)-3-methyl-2-(pent-2-en-1-yl)cyclopent-2-enone: 0.5 wt. -% 3-Butyl-5-methyltetrahydro-2H-pyran-4-yl acetate: 15 wt. -% 3-Pentyltetrahydro-2H-pyran-4-yl acetate: 50 wt. -% (Z)-hex-3-en-1-yl methyl carbonate: 5 wt. -% 3-(4-(tert-butyl)phenyl)-2-methylpropanal: 25 wt. -% 1-Methyl-4-prop-1-en-2-yl-cyclohexene: 85 wt. -% 2-(5-methyl-5-vinyltetrahydrofuran-2-yl)propan-2-ol: 1 wt. -% 3,7-Dimethylocta-1,6-dien-3-ol: 25 wt. -% 3,7-Dimethylocta-1,6-dien-3-yl acetate: 25 wt. -% (4E)-9-hydroxy-5,9-dimethyl-4-decanal: 10 wt. -% 3-Hydroxy-2-methyl-4H-pyran-4-one: 1 wt. -% Ethyl 2-methylpentanoate: 10 wt.-% (4-isopropylcyclohexyl)methanol: 5 wt.-% 3-Methyl-5-phenylpentan-1-ol: 10 wt. -% 2,6-Dimethylhept-5-enal: 2 wt. -% 2-isopropyl-5-methylcyclohexanol: 85 wt. -% 2-isopropyl-5-methylcyclohexanone: 2 wt. -% Methyl 2-aminobenzoate: 15 wt.-% Methyl benzoate: 1 wt.-% Methyl 3-phenylprop-2-enoate: 10 wt.-% 2-ethoxy-4-(methoxymethyl)phenol: 1 wt.-% Methyl 2-hexyl-3-oxocyclopentane-1-carboxylate: 5 wt. -% 6-Methylhept-5-en-2-one: 5 wt. -% 8-Methyl-1-oxaspiro[4.5]decan-2-one: 2 wt. -% Methyl nona-2-ynoate: 1 wt.-% Methyl 2-hydroxybenzoate: 1 wt.-% (Z)-3-methylcyclopentadec-5-enone: 0.5 wt. -% 4-(4-methylpent-3-en-1-yl)cyclohex-3-enecarbaldehyde: 2 wt. -% 7-Methyl-3-methyleneocta-1,6-diene: 0.5 wt. -% 2-Methylundecanoic acid: 0.5 wt.-% 2-(2-(4-methylcyclohex-3-en-1-yl)propyl)cyclopentanone: 50 wt. -% (E)-Methyl nona-2-enoate: 2 wt.-% (2Z)-3,7-dimethylocta-2,6-dien-1-ol: 10 wt. -% (E)-3,7,11-trimethyldodeca-1,6,10-trien-3-ol: 5 wt. -% 2-ethoxynaphthalene: 10 wt.-% (Z)-3,7-dimethylocta-2,6-dien-1-yl acetate: 0.5 wt. -% (E)-13-Methyloxacyclopentadec-10-en-2-one: 2 wt. -% (2E,6Z)-nona-2,6-dienal: 0.5wt. -% (2Z,6E)-2,6-nonadiene-1-ol: 0.1 wt.-% 5-Pentyloxolan-2-one: 15 wt. -% (Z)-non-6-enal: 0.5 wt.-% (Z)-Nona-6-en-1-ol: 0.5 wt. -% 2-(6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)ethyl acetate: 5 wt. -% 3-(4-(2-methylpropyl)-2-methylphenyl)propanal: 25 wt. -% Octan-2-one: 5 wt. -% 1-(2-naphthalenyl)-ethanone: 10 wt.-% (2-Methoxyethyl)benzene: 2 wt.-% 5-heptyldihydrofuran-2(3H)-one: 25 wt. -% 3,7-Dimethyloctan-1-ol: 10 wt. -% 2-Cyclohexylhepta-1,6-dien-3-one: 2 wt. -% 2-(phenoxy)ethyl 2-methylpropanoate: 10 wt.-% 2-Phenyl-ethanal: 0.5 wt.-% 2-Phenylethyl acetate: 15 wt.-% 2-Phenylethanol: 25 wt.-% 2-Phenylethyl 2-methylpropanoate: 2 wt. -% 2-Phenylethyl 2-phenylacetate: 5 wt. -% 3-Phenylpropan-1-ol: 1 wt. -% 6,6-Dimethyl-2-methylenebicyclo[3.1.1]heptane: 0.5 wt. -% 3-(6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)propanal: 0.1 wt. -% (2E,5E)-5,6,7-trimethylocta-2,5-dien-4-one: 2 wt. -% 1-Methyl-4-(4-methylpent-3-en-1-yl)cyclohex-3-enecarbaldehyde: 2 wt. -% 3-Methylbut-2-en-1-yl acetate: 10 wt. -% 4-(4-hydroxyphenyl)butan-2-one: 5 wt. -% 4-methyl-2-(2-methylprop-1-en-1-yl)tetrahydro-2H-pyran: 2 wt. -% 4-Methyl-2-phenyl-3,6-dihydro-2H-pyran: 2 wt. -% 3-Methyl-5-(2,2,3-trimethylcyclopent-3-en-1-yl)pentan-2-ol: 10 wt. -% Ethyl (Z)-2-acetyl-4-methyltridec-2-enoate: 0.5 wt. -% 4-(dodecylthio)-4-methylpentan-2-one: 0.5 wt. -% Cyclopentadecanone, hexadecanolide: 20 wt.-% 1-Phenylethyl acetate: 5 wt.-% (E)-6-Ethyl-3-methyloct-6-en-1-ol: 2 wt. -% (E)-2-((3,5-dimethylhex-3-en-2-yl)oxy)-2-methylpropylcyclopropanecarboxylate: 5 wt. -% 1-methyl-4-propan-2-ylcyclohexa-1,4-diene: 5 wt. -% 2-(4-methyl-1-cyclohex-3-enyl)propan-2-ol: 1 wt. -% 2-(4-methylcyclohex-3-en-1-yl)propan-2-ol: 25 wt. -% 1-Methyl-4-(propan-2-ylidene)cyclohex-1-ene: 15 wt. -% 2-(4-methyl-1-cyclohex-3-enyl)propan-2-yl acetate: 25 wt. -% 3,7-Dimethyloctan-3-ol: 50 wt. -% Oxacyclohexadecane-2-one: 10 wt. -% 2-isopropyl-5-methylphenol: 10 wt.-% 1-(cyclopropylmethyl)-4-methoxybenzene: 10 wt.-% (E)-Tridec-2-enenitrile: 15 wt.-% 3-Phenylbutanal: 5 wt.-% 3-(benzo[d][1,3]dioxol-5-yl)-2-methylpropanal: 5 wt. -% Undecane-2-one: 0.1 wt.-% (3E,5Z)-undeca-1,3,5-triene: 0.1 wt.-% (E)-4-methyldec-3-en-5-ol: 25 wt. -% 4-Hydroxy-3-methoxybenzaldehyde: 5 wt. -% (Z)-cyclohexadec-5-enone: 0.1 wt.-% 2E,6Z)-nona-2,6-dienenitrile: 0.1 wt. -% 2-Methoxynaphthalene: 15 wt.-%.
4. The encapsulated composition of claim 2 or 3, wherein each of the biodegradable component(s) is present at a concentration equal to or greater than a minimum concentration of 0.01 wt.-%, preferably 0.02 wt.-%, more preferably 0.05 wt.-%, even more preferably 0.1 wt.-%, and even more preferably 0.5 wt.-%.
5. The encapsulated composition according to any one of claims 1 to 4, wherein the water-soluble matrix comprises at least one material selected from the group consisting of starch, in particular water-soluble modified starch, maltodextrin, mannitol, chitosan, gum arabic, alginate, cellulose, pectin, gelatin, polyvinyl alcohol and mixtures thereof.
6. 6. The encapsulated composition of claim 5, wherein the water soluble matrix comprises a water soluble modified starch selected from the group consisting of bleached starch, hydroxypropyl starch, hydroxypropyl distarch phosphate, hydroxypropyl distarch glycerol, acetylated distarch phosphate, starch acetate esterified with acetic anhydride, starch acetate esterified with vinyl acetate, acetylated distarch adipate, acetylated distarch glycerol, starch sodium octenyl succinate, and mixtures thereof.
7. 7. The encapsulated composition of claim 6, wherein the water soluble matrix additionally comprises a material selected from the group consisting of maltodextrin, mannitol, and mixtures thereof.
8. The encapsulated composition of any one of claims 5 to 7, wherein the water-soluble matrix additionally comprises hemicellulose.
9. 9. The encapsulated composition of claim 8, wherein the hemicellulose is a xyloglucan, especially a xyloglucan obtainable from tamarind seeds.
10. 10. The encapsulated composition of any one of claims 1 to 9, wherein the perfume composition is at least partially encapsulated in a core-shell microcapsule comprising a core and a shell surrounding the core.
11. 11. The encapsulated composition of claim 10, wherein the perfume composition is fully encapsulated in a core-shell microcapsule.
12. The encapsulated composition according to any one of claims 1 to 11, wherein the proportion of the perfume composition is from 10 to 50 wt.-%, preferably from 20 to 47.5 wt.-%, even more preferably from 30 to 45 wt.-%, relative to the total weight of the encapsulated composition.
13. The encapsulated composition according to any one of claims 1 to 12, wherein the proportion of the water-soluble matrix is from 30 to 90 wt.-%, preferably from 35 to 80 wt.-%, even more preferably from 40 to 70 wt.-%, relative to the total weight of the encapsulated composition.
14. The encapsulated composition according to claim 10, wherein the proportion of the perfume composition encapsulated in the core-shell microcapsules is from 5 to 30 wt.-%, preferably from 7 to 25 wt.-%, even more preferably from 10 to 20 wt.-%, relative to the total weight of the encapsulated composition.
15. The encapsulated composition of any one of claims 1 to 14, wherein the composition is in particulate form.
16. 16. A powder formulation comprising the encapsulated composition of claim 15.
17. 17. The powder formulation of claim 16, additionally comprising a solid carrier.
18. 18. The powder formulation of claim 17, wherein the solid carrier is selected from the group consisting of urea, sodium chloride, sodium sulfate, sodium acetate, zeolite, sodium carbonate, sodium bicarbonate, clay, talc, calcium carbonate, magnesium sulfate, gypsum, calcium sulfate, magnesium oxide, zinc oxide, titanium dioxide, calcium chloride, potassium chloride, magnesium chloride, zinc chloride, sugars, polyethylene glycol, polyvinylpyrrolidone, citric acid or any water soluble solid acid, fatty alcohol, fatty acid and mixtures thereof.
19. 19. The powder formulation according to any one of claims 16 to 18, wherein the proportion of the encapsulated composition is 0.1 to 50 wt.-%, preferably 1 to 30 wt.-%, even more preferably 3 to 15 wt.-%, based on the total weight of the powder formulation; and the proportion of the solid carrier is 10 to 99.9 wt.-%, preferably 30 to 97 wt.-%, even more preferably 50 to 95 wt.-%, based on the total weight of the powder formulation.
20. A process for preparing an encapsulated composition, in particular a composition according to any one of claims 1 to 15, comprising the following steps: a) preparing an emulsion or suspension of a fragrance composition in a solution of a matrix material in water; b) subjecting the emulsion or suspension to drying (in particular spray drying or adsorption onto an absorbent body) to obtain an encapsulated composition, in which the perfume composition is entrapped in a water-soluble matrix; wherein the perfume composition comprises, preferably consists of, at least one, preferably at least two, more preferably at least four, even more preferably at least eight, even more preferably at least sixteen biodegradable ingredient(s), wherein the biodegradable ingredient(s) are present in a total concentration of at least 75 wt.-%, preferably at least 80 wt.-%, more preferably at least 85 wt.-%, even more preferably at least 90 wt.-%, even more preferably at least 95 wt.-%, based on the total weight of the perfume composition; The above process.
21. An encapsulated composition obtainable by the process according to claim 20.
22. A consumer product, preferably a fabric care product, a home care product or a personal care product, comprising an encapsulated composition according to any one of claims 1 to 15 or 21 or a powder formulation according to any one of claims 16 to 19.
23. A solid fragrance booster composition comprising an encapsulated composition according to any one of claims 1 to 15 or 21 or a powder formulation according to any one of claims 16 to 19, and a solid vehicle.
24. 24. The solid fragrance booster composition of claim 23 in the form of a plurality of pastilles.
25. 25. A solid fragrance booster composition according to claim 23 or 24, additionally comprising a non-encapsulated perfume composition.
26. 26. The scent booster composition of any one of claims 23 to 25, additionally comprising a core-shell microcapsule comprising a core and a shell surrounding the core, which does not form part of the encapsulated composition of any one of claims 1 to 15 or 21 or the powder formulation of any one of claims 16 to 19.
27. 27. The scent booster composition according to any one of claims 23 to 26, wherein the solid vehicle has a melting temperature of from 40°C to 160°C, preferably from 60°C to 140°C, more preferably from 80°C to 120°C, wherein the solid vehicle preferably crystallizes below its melting temperature.
28. 28. The scent booster composition according to any one of claims 23 to 27, wherein the solid vehicle comprises, preferably consists of, a polyol or polyether, preferably a sugar alcohol or polyethylene glycol, especially a sugar alcohol selected from the group consisting of erythritol, threitol, arabitol, xylitol, ribitol, mannitol, galactitol, fucitol, iditol and inositol, even more preferably xylitol.
29. A solid scent booster composition according to any one of claims 23 to 28, wherein the proportion of the encapsulated composition according to any one of claims 1 to 15 or 21 or the powder formulation according to any one of claims 16 to 19 is between 1 wt.-% and 40 wt.-%, preferably between 5 wt.-% and 30 wt.-%, even more preferably between 10 wt.-% and 20 wt.-%, relative to the total weight of the solid scent booster composition.
30. Use of an encapsulated composition according to any one of claims 1 to 15 or 21 or a powder formulation according to any one of claims 16 to 19 to obtain a consumer product.
